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ABSTRACT
Professional antigen presenting cells (APCs) represent an important link between the
innate and adaptive imune system. Macrophages (M s) and dendritic cells (DCs)
serve as sentinels in the periphery collecting samples from their environment and
processing ths information. These cells then present antigenic fragments to T cells in the
context of self-MHC molecules. Although a clear role for both of these APCs in the
stimulation of already activated or memory T cells has been established, the abilty of
s to activate naive T cells is stil unown. In ths thesis the ability of bone marow-
derived M s and DCs to prime naive CD8+ and CD4+ T cells was investigated. Using
adoptively transferred transgenic CFSE-Iabeled P- 14 T cells, specific for gp33 from
lymphocytic choriomenigitis virus in the context of D , we were able to demonstrate the
abilty of both M s and DCs to induce naive CD8+ T cells proliferation. Once primed by
s these T cells gained effector fuction as shown by interferon- y (IFN-y) production
and in vivo cytolysis. In addition, imunzation of wild type anmals with gp33-pulsed
, as well as DCs, led to greater than a 95% reduction in lymphocytic
choriomeningitis virus titers. To rule out the role of cross-presentation in the observed
priming, two models were used. In the first model, lethally irradiated F 1 bxs chimeras
reconstituted with either H- or H-2 b bone marow were used as host for the adoptive
transfer experients. Since the gp33 peptide binds to D , the H- reconstituted animals
should be unable to cross-present the peptide to the P- 14 T cells. U sing this model, we
were able to clearly demonstrate the ability of M s to activate naive P- 14 T cells to
undergo division. Additional experiments, demonstrated that these M primed T cells
went on to develop into effector cells. Finally, the ability ofthe M~ primed T cells to
develop into fuctional memory cells was demonstrated. To confrm the chimera results
these experiments were repeated using (32 microglobulin deficient animals (whose cells
don t express MHC I) as host in adoptive experiments. M~s were able to stimulate the
naive P-14 T cells to divide and gain effector fuction as demonstrated by the ability to
produce IFN-y. In contrast to the CDS system, M~ were poor stimulators ofDOll.
CD4+ T cell proliferation. Additionally, DOl1.lO T cells stimulated by DCs were able to
produce interleuk-2 (IL-2), IL- tuor necrosis factor and granulocyte-macrophage
colony stimulating factor where as M~ stimulated DOl1.lO T cells were only able to
produce IL-2. In conclusion this body of work clearly demonstrates the in vivo ability of
M~ to stimulate CDS+ T cell proliferation, effector fuction, as well as the formation of
fuctional CDS+ T cell memory. Whether or not the natue of the memory pools
stimulated by the two APCs is exactly the same is stil unown and needs fuer
investigation. The abilty of APCs other than DCs to stimulate fuctional protective
memory needs to be considered in the quest to design vaccines that offer broad-spectr
protection.
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Chapter I: Introduction
. .
The ability of an organsm to fight off infection by other organsms is dependent
on its immune system. The imune system consists of two parts, innate immunty and
adaptive immunity. Innate immunity evolved first, appearing in invertebrates such as
Drosophila and C. elegans. In the vertebrates, inate immunty acts as the first line of
defense against infection. Some components of the innate immune system are
complement, interferons a/f3, natual killer cells (NK) and the mononuclear phagocyte
system including dendritic cells, macrophages and granulocytes. The phagocytes of
innate immunty can be activated by the binding of the pathogens to the pattern
recognition molecules, Toll-like receptors, on their surace. These cells are also activated
by the infamatory cytokines. Activated phagocytes then engulf the invading organsm
and destroy it using microbicidal molecules including reactive oxygen intermediates.
Since mamalian cells generally do not express the molecular patterns that the Toll-like
receptors recognize, they signal the immune system that the host is being invaded. The
innate immune system recognizes unprocessed antigens such as carbohydrates (Poltorak
et aI. , 1998), double stranded RNA (Alexopoulou et aI., 2001) and DNA (Hemmi et aI.
2000). In ths maner innate immunty is signaled to the presence of a foreign invader 
receptors with limited numbers of specificities (Aka, 2003; Takeda et aI., 2003).
Adaptive imunty first appeared in the vertebrates and consists of the
lymphocytes, Band T, which respond in an antigen specific maner. Both Band T cells
possess surace antigen receptors that undergo gene rearangements and selection during
development (LeFranc et aI., 1986; Reth and Alt, 1984; Seide and Kehoe, 1983;
Waldman et aI. , 1985). The various stages of gene rearangements and the process that
allows for the gene breaks to be repaired generate the tremendous variability in both the
T cell and B cell repertoire. This large variability in the repertoire results in an
organism s ability to recognize any pathogen and ward off infection. Although B cells
can recognize and bind whole antigens, T cells respond only to antigenic fragments
displayed in the correct context. The cells responsible for the initial processing and
correct presentation of antigen to the adaptive immune system, thereby alerting it as to
whether or not an imune response is needed are of bone marow origin (Beutler, 2004).
Whle it has been thought that dendritic cells are the key cells that car out this
sureilance fuction, ths thesis demonstrates that macrophages also car out this
important fuction. In this process macrophages and dendritic cells act as sentinels in the
periphery collecting samples from their environment and processing this inormation.
These phagocytes then display antigenic fragments on their cell surace in the context of
the correct major histocompatibility complex. These cells also express surface
molecules such as CD80 and CD86 that aide in their ability to activate T cells. Both
macrophages and dendritic cells secrete varous cytokines and chemokies to fuher
attract and activate T cells. By collecting, processing and presenting antigens,
macrophages and dendritic cells allow for the transfer of antigenic information from the
innate immune system to the adaptive immune system. Antigen presenting cells (APC)
are the cells that serve as the link between the two components of the immune system and
are the subjects of this thesis.
Antigen Processing and Presentation
Endogenously synthesized antigen and MHC Class I
Class I molecules are found on all nucleated cells in the body. Classical Class I
molecules consist of heavy chains and f32 microglobulin (f32m). The f32m molecule aids
in the folding and the stabilization of the class I molecule. The class I pathway samples
cellular proteins that are targeted to the proteosome for degradation (Gaczynska et aI.
1993; Goldberg and Rock, 1992). The proteosome generates peptides with the correct C
terminus, but varous extensions on the N-termnus (Mo et aI. , 1999). These peptides
then bind to the transporter associated with antigen processing (TAP) protein and are
transported into the endoplasmic reticulum (Monaco, 1992) where N-extended precursors
can be trimmed by amino peptidases (Mo et aI., 1999). The matue epitopes bind to the
newly formed class I, f32-microglobulin complex, and then these new class I molecules
follow the default exocytosis pathway to be displayed on the cell surace (Rock et aI.
2004; York et aI. , 1999; York and Rock, 1996).
Exogenous Antigen And MHC Class I
Another pathway for the generation of peptides for class I exists exclusively in
professional APCs (Huang et aI. , 1994a; Huag et aI. , 1994b; Sigal et aI. , 1999; Sigal and
Rock, 2000). This pathway is called the exogenous class I pathway or cross-presentation
pathway (Bevan, 1976a; Bevan, 1976b). Antigens destined for this pathway enter the
APCs though endocytic mechansms e.g. phagocytosis of debris or apoptotic blebs from
inected cells. Once in the phagolysosomes, there are two possible fates for these
antigens: a T AP- dependent (Huag et aI. , 1996; Song and Harding, 1996) and T AP-
;.-- _
independent pathway (Bachman et aI. , 1995; Sigal and Rock, 2000). In the T AP-
dependent pathway, the mechanism by which the peptides exit the phagosome and enter
the cytoplasm is largely unclear, but might involve Sec 61 (Tsai et aI. , 2002). Once in the
cytoplasm these antigens are broken down by the proteosome into peptide fragments.
These peptides are then transported into the ER via the TAP transporter and loaded onto
newly synthesized class I molecules. In contrast, the TAP-independent presented
peptides are generated in the endocytic comparment, and this process has recently been
shown to be dependent on Cathespsin S (Rock, 2003; Shen and Rock, 2004). These
cross-presentation pathways have been shown to playa very importt role in vivo in the
immunity to viruses and pathogens that do not infect professional antigen presenting cells
and possibly in all inections (Belz et aI. , 2004; den Haa and Bevan, 2001; Lenz et aI.
2000; Rock, 2003)
Loading Of Class II MHC Molecules
In contrast to class I molecules, class II molecules are only found on professional
APCs. Class II molecules are synthesized as a heterodimer consisting of a and f3 chains
(Neefjes and Ploegh, 1992). Invarant chain associates with the af3 heterodimer and
stabilizing its strctue, blocking its peptide binding groove and directing its transport. 
the endocytic comparment cysteine and asparic proteases digest the invarant chain
leaving a peptide fragment in the peptide-binding groove termed CLIP (Class-II-
associated invarant chain peptide). Antigens destined to be presented on class II
molecules enter the APC through endocytosis, pinocytosis or phagocytosis (Harding et
aI. , 1991; Harding and Song, 1994; Neefjes et aI., 1990). After internalization, the
antigen is broken down by the proteases present in the endocytic comparments such as
the cathepsins (Driessen et aI. , 1999; Pluger et aI. , 2002). In antigen presenting cells
there is a specialized endosomal/lysosomal comparment termed MHC class II
compartment (MIIC), where the CLIP peptide is exchanged for an antigenic peptide
(Peters et aI. , 1991). The CLIP peptide can also be removed in a comparent called
CIIV , which is a multivesicular comparment that more closely resembles endosomes
(Amigorena et aI. , 1994; Amigorena et aI. , 1995). The accessory molecule H-2DM
catalyzes this peptide exchange. These molecules then travel to the surace via the
default exocytosis pathway. The peptides that bind to class II are generally longer than
those that bind class I , about 12 amino acids long (Nelson et aI. , 1993; Nelson et aI.
1992; Rudensky et aI. , 1991). Class II molecules can also be loaded after being recycled
from the cell surace (Sinnathamby and Eisenlohr, 2003). Class II antigen processing and
presentation is reviewed in Bryant et aZ. (Bryant and Ploegh, 2004).
Professional Antigen Presenting Cells
B cells, dendritic cells (DCs) and macrophages (M~) are all professional antigen
presenting cells (APCs). Although all nucleated c lls express class I and can present
peptide on MHC class I molecules to CD8+ T cells, only professional APCs can provide
the T cells with the necessar costimulatory signals leading to T cell stimulation.
Professional APCs (specifically M~ and DCs) are the only cells that have the abilty to
present exogenously acquired antigens on class I molecules (Harding and Song, 1994;
Rock et aI. , 1993). This specialized fuction is termed cross-presentation and is
importt in imunity to viruses that don t infect APCs and in tuor sureilance (see
above) (Belz et aI. , 2004; den Haa and Bevan, 2001; Lenz et aI. , 2000; Rock, 2003). In
addition, a professional APC has all the necessar molecules for the efficient antigen
presentation to T cells including MHC class I , MHC class II , co stimulatory molecules
B71/B72 and CD40 (Banchereau et aI. , 1995). Professional APCs also express adhesion
molecules and chemokine receptors, which allow them to home to the secondar
lymphoid tissue (Banchereau and Steinman, 1998). DCs and M~s resident in the tissues
or circulating in the blood gather antigenic information from the local environment and
then migrate to the secondar lymphoid organs (Matsuno et aI. , 1996). APCs that reside
in the lymph nodes and spleen may also acquire antigen from lymph fluid or blood
respectively. These cells then generate peptides from the antigens they have acquired and
display them on their MHC class I and class II molecules. Once in the lymphoid tissue
the APCs will present these peptide-MHC class I and class II complexes and
co stimulatory molecules to naive T cells and initiate an immune response. The main job
of these cells is to act as sentinels in the periphery (Austyn, 1996; Banchereau and
Steinman, 1998)
B cells as APCs
B cells have the ability to be both APCs and antibody-secreting cells. Although B
cells typically acquire and present soluble antigens, they can in some circumstaces also
present pariculate antigen on Class II. Using T-T hybridomas as a read out, Vidard et al.
demonstrated that B cells can present pariculate antigens on MHC II very effectively
when activated by LPS and that presentation is enhanced if the B cells imunoglobulin
receptor can bind the antigen. These authors went on to show that the epitopes presented
by the B cells differed from the epitopes presented by the M~s (Vidard et aI. , 1996).
Another study suggests that entry of antigen into the B cell after binding to the
immunoglobulin receptor may lead to an accelerated processing pathway for Class II
containing novel comparments (Cheng et aI. , 1999).
B Cells Can Present Antigen To Naive T Cells In Vitro
There is abundant literatue on the ability of B cells to present antigen and
stimulate previously activated CD4+ T cells in vitro (Ashwell et aI. , 1985; Bottomly and
Janeway, 1989; Duncan and Swain, 1994; Kur-Jones et aI. , 1988; Liano and Abbas
1987; Lichtman et aI. , 1987; Linton et aI. , 2003; Malynn et aI. , 1985; Morokata et aI.
1995; Webb et aI. , 1985; Webb et aI., 1989; Zimecki et aI. , 1988). It has also previously
been shown that small B cells can stimulate mixed lymphocyte reactions as well as Mlsa
-reactive T cells (Webb et aI., 1985; Webb et aI. , 1989). The abilty of resting B cells to
present antigen to CD4 T cells in vitro has also been previously demonstrated (Liano and
Abbas, 1987; Lichtman et aI., 1987). In addition, activated (e.g. anti-Ig and IFN-
y) stimulated B cells express B7.2 , HSA and ICAM- 1 (Morokata et aI., 1995). Therefore
activated B cells express many of the molecules needed to activate naive T cells, makng
them potent stimulators ofT cell responses. These anti- and IFN-y stimulated B cells
were able to stimulate naive CD4+ T cells to proliferate (Morokata et al. , 1995).
Blocking experiments demonstrated that the expression ofB7.2 was critical for the B
cells to fuction as APCs. Although the naive cells responded to this stimulation
CD45RBIow memory cells proliferated minimally, suggesting that B cells may be more
potent stimulators of naive T cells than of memory T cells (Morokata et aI. , 1995).
Using transgenic mice specific for a peptide derived from pigeon cytochrome C
Duncan et al. showed that both isolated activated B cells and bone marow-derived M~s
had the ability to stimulate naive CD4+ T cells to become Th effector cells in vitro. The
ability to skew the effector population with exogenous IFN-y or IL-4 was irrespective of
the stimulating APC. M~s and B cells were equally capable of restimulating Th1 or Th2
effector cells. These authors went on to a note a difference of the 2 types of APC in their
ability to skew effector ThO development. Whereas stimulation of T cells with B cells
led to secretion of more IFN-y, stimulation of effector ThO cells with M~s led to
secretion of more IL-4 (Duncan and Swain, 1994).
B Cells Can Present Antigen To Naive T Cells In Vivo
Using mice lacking B cells, Constat et al. demonstrated a role for B cells in the
presentation of protein antigens. These mice were stil able to mount responses to
peptide antigens. Ths group went on to fuher demonstrate that B cells pulsed with
protein antigen in vivo up-regulated expression ofB7.2 (Constat et aI. , 1995b). Yet
another study performed by Ron et al. also demonstrated a role for B cells in T cell
priming. Using mice that lack Ig + B cells and are unable to mount T cell proliferative
responses; these authors showed that ths defect could be rescued by the injection of
purfied B cells one day before administration of peptide and adjuvant (Ron and Sprent
1987). These data suggest a clear role for B cells in T cell priming, but a conficting
report by Fuchs et al. demonstrated that although B cells can present antigen to memory
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T cells, they are unable to prime naive T cells (Fuchs and Matzinger, 1992). A more
recent study demonstrated that B cells could present antigen to CD4+ T cells in vivo.
These authors also showed that costimulation via OX40L leads to the development of
Th2 cells. These CD4 + T cells are able to expand and secrete cytokines (Linton et aI.
2003). Taken together these studies demonstrate that under the right conditions with
proper activation B cells can present antigen efficiently to naive T cells. In addition the
stimulation of CD4+ T cells by different types of APCs may determne the effector
cytokines made by those CD4+ T cells.
Dependence on CD40-CD40L
The ability ofB cells to stimulate naIve CD4+ T cells is dependent on B cell
activation. Ligation of CD40 on B cells appears to be importt for activating B cells
whereas priming of T cells by naIve B cells frequently leads to the induction oftolerance.
CD40 is a member of the tuor necrosis factor (TNF) superfamily of receptors and is
expressed on professional APCs, epithelial cells, fibroblast and mast cells among others.
The ligand for CD40, CD40L also known as CD 154 is expressed on T cells, NK cells
mast cells and other cell types. The ligation of CD40 by CD40L on Th cells is critical
in the activation of B cells and antibody responses. The engagement of CD40 by its
ligand leads to the up regulation ofCD80, CD86 , and CD54 (LFA- 1) as well the
secretion of varous cytokines and chemokines by the B cells. B cells activated by CD40-
CD40L interactions secrete IL- , IL- 6 TNF IL- 1 0 and IL- , which are important
mediators of immune responses (Van Gool et aI., 1996; VanKooten and Banchereau
1996; van Kooten and Banchereau, 1997a; van Kooten and Banchereau, 1997b; van
Kooten and Banchereau, 1997c; van Kooten and Banchereau, 2000). Mice deficient in
CD 154 have reduced proliferative responses to protein antigens, are unable to mount
CTL and do not develop autoimmune diseases in some model systems. Inhbition of
CD40-CD 154 interactions , either by blockade or genetic knockout, blocks humeral
responses to T dependent antigens (responses dependent on Th2 help), graft versus host
disease and rejection of tissue allografts (Boussiotis et aI.
, 1996; Boussiotis et aI. , 1994).
Some of these observed defects may be due to the absence of CD40 on other APCs such
as DCs and M~s.
Using splenic APCs from CD40-deficient and wild type mice to prime CD4 + T
cells expressing the transgenic TCR for ovalbumin (D011.1O cells) in vitro Ozak et aI.
showed that CD40- splenocytes were able to induce good proliferation of the CD4 + T
cells to ovalbumin, concluding that in the presence of high peptide concentration the
ability of splenic APCs to stimulate T cell responses is independent of CD40-CD 154
interactions. These authors went on to show that
, when resting B cells were isolated from
the CD40-deficient mice, the B cells were unable to stimulate naIve T cells. Using super
antigens to prime naive T cells, the authors confIrmed the ability of the B cells from
knockout animals to present strong antigenic stimuli to the T cells (Ozak et aI. , 1999).
In conclusion, although naive B cells can present high dose antigens
, only B cells
activated through the B cell receptor and CD40 ligation are able to stimulate naive T cells
when antigen is limiting.
The Role Of B Cells In Cross-presentation
The ability ofB cells to cross-present exogenous antigen on class I molecules is
limited. In studies isolating M~s and B cells from murne spleens and testing their
ability to present peptides from ovalbumin to CTL clones, Rock et al. demonstrated that
B cells were unable to present antigens via this pathway (Rock et al. , 1993). On the other
hand, a recent study has shown that B cells are able to cross-present bead bound ova to
CD8 T cells if the bead was also conjugated to CpG-DNA (Heit et aI. , 2004). The abilty
ofB cells to cross-present antigen when activated via the toll receptor pathways
highlights the differences in the ability of resting and activated B cells to effciently
cross-present antigen.
Dendritic Cells
DCs are professional APCs that reside in most tissues in the body and act as
sentinels in the immune system. In the peripheral tissues, DCs are constatly "sampling
the environment and internalizing antigens. DCs then process and present these antigens
to T cells. The abilty to process and present both self and nonself antigens allows DCs
to playa role in both the initiation of T cell activation and in T cell tolerance and anergy.
In the tissues DCs exist in an immatue state in which they are highly phagocytic
and express only low levels of MHC class II and the costimulatory ligands CD80 and
CD86. Once DCs acquire antigen and receive activation signals, e.g. from CD40-
CD40L interactions, Toll receptor signals and/or exposure to infamatory cytokies
they begin a matuation process and migrate to the lymph nodes (Denzin et aI. , 1996;
Reis e Sousa, 2004a; Reis e Sousa, 2004b). After the DCs matue, they are no longer
phagocytic, but express high levels ofMHC Class II molecules (Pierre et aI. , 1997) (Cella
et aI. , 1997a), CD80, CD86 (Caux et aI., 1994; Inaba et aI. , 1995; Inaba et aI. , 1994) and
secrete varous cytokines such as IL- 12 (Cella et aI., 1996). In this matue state DCs are
found in the T cell zones of the secondar lymphoid organs where they are able to
interact with and activate naive T cells.
All DCs arse from bone marow precursor cells. Possibly due to the importce
of their fuction, DCs are a very heterogeneous population of APCs. Since a marker
specific to the dendritic cell lineage has yet to be identified, DCs are curently defined by
varing criteria including lineage, surace markers, matuation, anatomical location and
abilty to present antigen to naive T cells. How all these subpopulations relate to one
another is stil not entirely clear. Mouse spleens contains 3 major subsets ofDCs
distinguished by the expression of varous cell markers CD8+ DEC 205 , CD4+ and CD4-
CD8-. Whereas mouse lymph nodes contain 6 known subsets: CD8+ CD205high CD 11 b 
(Langerhan cells); CD8+ CD205 gh CD11b- (lymphoid DCs); CD4+ CD11b+; CD4- CD8-
CD205+ CD 11 b + ; CD4- CD8- CD205- CD 11 b + and CD45RA + (B220 ) (plasmacytoid
DCs) (Belz et aI., 2002c; Henr et aI., 2001; Kamath et aI. , 2000; Vremec and Shortman
1997).
Generally, DCs can be grouped into 2 major subsets based on their phenotype:
lymphoid DCs (CD8 ) and myeloid DCs (CD8- CD4+). The lymphoid DCs are CD8a
homodimer positive , CD11c , DEC205+ and CD11b+. Lymphoid DCs are thought to be
less phagocytic than myeloid DCs and produce higher levels ofInterleukn- 12 (IL-12),
upon stimulation. In response to IL- 12 lymphoid DCs can produce IFN-y (Banchereau
and Steinman, 1998). Myeloid DCs arse from a common myeloid precursor in the
presence of Granulocyte/macrophage colony-stimulating factor and are characterized by
the expression of CD lIb and CD11c but lack CD8a and DEC205. Bone marow-
derived, CD 11 b + CD 11 c myeloid DCs are the subject of this thesis. Whch of the above-
mentioned in vivo populations ths in vitro raised population of DCs represents is stil
unown and is curently under investigation.
In Vitro Evidence For The Abilty Of DC To Present Antigen To CD4+ T Cells
There is abundant literatue supporting a role for DCs in the in vitro stimulation of
CD4+ T cells. One of the fIrst observations made about the imunostimulatory role of
DCs was their ability to induce primar mixed leukocyte reactions (MLR) in mice.
Using splenic DCs, Steinman et al. showed that as few as 300- 1000 DCs could stimulate
very potent proliferative activity of responding splenic T cells and that 100 000 DCs was
able to induce maximum T cell proliferation of 30-80 fold. DCs were also shown to have
100-300 times more MLR-stimulating ability than unactionated spleen cells. In
addition, depletion of splenocytes of T or B cells had no affect on the abilty of these cells
to stimulate MLR. This group fuher demonstrated that DC-depleted cell populations
that were enrched for mononuclear phagocytes were able to stimulate MLRs very
weaky (Steinman et aI. , 1983; Steinman and Witmer, 1978). Another early paper
showed that DCs were also able to stimulate unprimed syngeneic T cells to proliferate in
the absence of antigen. This activity is termed a syngeneic mixed leukocyte reactions. It
was fuher demonstrated that the ability of DCs to stimulate alloreactive T cells was 10-
fold greater than their abilty to stimulate syngeneic T cells (Nussenzeig and Steinman
1980). In addition, Inaba et at. demonstrated that Bacilus Calmette-Guerin (BCG) -
pulsed DCs could induce proliferation in vitro ofBCG-specific T cells isolated from
animals immunzed with BCG and an adjuvant (Inaba et aI., 1993).
In Vivo Evidence For The Abilty Of DC To Present Antigen To CD4 T Cells
Using dye labeled D011.1O CD4+ transgenic T cells (specific for the OVA
peptide 323-339) and an adoptive transfer system, Ingull et al demonstrated clustering of
transgenic T cells around dye labeled peptide-pulsed APC. Additionally, this group
demonstrated the ability of the transgenic T cells to expand and secrete IL-2 in the mice
that received the adoptively transferred peptide-pulsed DCs. In fuer experiments, the
ability of the primed CD4+ T cells to initiate a delayed type hypersensitivity response was
demonstrated (Ingulli et aI. , 1997). In another set of experiments by ths same group, a
role for CD 11 b + DC in the presentation of soluble OVA to CD4+ T cells was
demonstrated (Ingull et aI., 2002). In these experiments, DO 11. 1 0 T cells were
adoptively transferred into BALB/c hosts. Twenty-four hours later, the mice were
inoculated subcutaeously with fluorochrome labeled OV A. When the draining lymph
nodes were removed eighteen hours later and analyzed by F ACS , CD8+ DCs, a sub
population ofB cells and M~ contained low amounts ofOV A, whereas a subpopulation
of CD 11 b + DCs contained large amounts of OV A. This group went on to show that only
CD11b+ DCs sorted from soluble OVA injected mice could stimulate D011.1O T cells to
proliferate in vitro. The inabilty of the CD8+ DC to present OVA in vivo is interesting,
since when given soluble OVA in vitro the CD8+ DC were able to generate the correct
peptide-MHC complexes and present antigen to T cells. Since most of the CD11b+ DCs
are in the paracortical region near the B cell region and the CD8+ DCs were equally
distributed throughout the paracortex, the authors suggested that one possible explanation
for ths discrepancy might be that subcutaeously delivered soluble antigen is sequestered
in certain comparments (Ingull et aI. , 2002). This observation suggests that the type of
antigen as well as the route of entr into the body may determne the most effcient APC
for antigen presentation to T cells.
Studies involving immunity to intracellular parasites also demonstrate a role for
DCs in the presentation of antigen to CD4+ T cells. Flohe et al. demonstrated that
immunzation with Langerhan and DCs pulsed with Leishmania major in vitro could
protect BALB/c mice from a lethal challenge whereas; imunzation with 1. major
pulsed M~s did not offer protection (Flohe et al. , 1998; Moll and Flohe, 1997). Since
immunty to 1. major had previously been shown to depend on the activation of CD4+ T
cells, activation of these cells was inferred from the observed protection (Erb et aI.
1996). A role for antigen pulsed DCs in imunty to mycobacteria has also been
demonstrated. Inaba et al. showed that BCG-pulsed BM-derived DCs could induce
immunty to BCG in naive mice. By antibody depletion and blockig studies, this group
fuher demonstrated that the proliferating cells isolated from these mice were CD4+ T
cells (Inaba et aI. , 1993).
In Vitro Evidence For The Abilty Of DC To Present Antigen To CDS+ T Cells
Although proliferation of T cells in a MLR is thought to be primarly proliferation
ofCD4+ T Cells, CDS T cells are also induced to proliferate in this system. Steinman 
at. also showed that during a MLR, DCs were also able to induce alloreactive cytotoxic T
cells (CTL), clearly demonstrating a role for DCs in the in vitro priming ofCD8+ CTL
(Steinman et aI. , 1983).
Using DCs exposed to exogenous antigen from cytomegalovirus (CMV), two
groups have demonstrated that DCs can process and present viral epitopes to human
CD8+ T cells, leading to expansion of CMV -specific T cells. Once expanded, the CTLs
were able to lyse peptide-pulsed tagets in vitro (Kleihauer et aI. , 2001; Peggs et aI.
2002). Transfusion of the T cells activated and expanded by peptide-pulsed DCs into
transplant patients, in which CMV has reactivated, leads to a reduction in viral burden
(Einsele et aI. , 2002). Others have shown that human DC' s pulsed with known CTL
epitopes can present antigen to both naive and memory CTL (Wong et al. , 1998).
In Vivo Evidence For Abilty Of DC To Present Antigen To CDS T Cells
Although it is presently thought that DCs are the only cells that can stimulate
naive T cells in vivo (Banchereau and Steinman, 1998), experimental evidence for ths
concept is largely lacking (see below). There is considerable evidence that DCs can
acquire and present antigen in vivo. By transferrng in vitro OVA-loaded f32m-deficient
splenocytes into wild type animals, den Han et al. demonstrated that CD8+ DCs could
cross-present OVA and prime CD8+ CTL (den Haa et aI. , 2000). Similarly, Pooley 
al., using intravenously administered soluble OVA, demonstrated a role for CD8+ DCs in
the presentation of soluble OVA to CD8+ T cells. However, in the same study, a role for
CD8- DCs in the presentation of OV A to CD4+ T cells was clearly established (Pooley et
aI. , 2001). Many other experiments have shown that in immunized animals, DCs that are
presenting the injected antigen can be recovered.
There is also considerable data showing that injection of antigen-bearng DCs into
mice can prime T cell responses. Many studies have tried to use DCs loaded with antigen
ex vivo to initiate CD8+ T cell responses in vivo against tuor antigens (Celluzi et aI.
1996; Gabrilovich et aI. , 1996; Paglia et aI. , 1996; Tjandrawan et aI. , 1998; van
Broekhoven et al. , 2004). One such study performed by Paglia et aZ. used BM-derived
DCs loaded in vitro with soluble Beta-galactosidase (f3-gal) as a model. This group
demonstrated that when transferred into BALB/c mice intraperitoneally, these antigen-
loaded DCs were able to induce CTLs. In addition, antigen-loaded DCs could be used to
imunize mice against f3-gai. Once imunzed, 60 % of these mice were protected from
tuor challenge with f3-ga1 expressing tuors. If the immunized mice were boosted with
soluble f3-gal 5 days after priming, they were completely protected from tuor challenge
(Paglia et aI. , 1996). In another model system Porgador et al. found similar results.
These authors found that a single immunzation of mice with OV A peptide-pulsed DCs
was sufficient to elicit a protective immune response against a challenge with an OV 
expressing tuor (Porgador et aI. , 1996). In another study, these same authors
demonstrated the priming of naive CTL in mice immunzed with OV A peptide pulsed
DCs (Porgador and Gilboa, 1995). A study by Gabrilovich et aZ. took these observations
one-step fuher. These authors demonstrated a role for peptide-pulsed dendrtic cell
immunzation in the rejection of established tuors in tuor bearng mice. These
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authors found that although a single immunization with mutat p53-pulsed DCs had no
effect on tuor size , repeated imunizations led to arested tuor growth and prolonged
surival. Additionally, these authors showed a switch in the Th1/Th2 profies of the
treated mice. Tumor bearing mice showed a predominately Th2 profile in cytokine
secretion, whereas mice treated with peptide-pulsed DCs displayed a more Th I-type
profie of cytokine secretion. Another interesting observation made by these authors is
that only DCs made from the bone marow of tuor bearng mice and not splenic DCs
had an effect on tuor progression (Gabrilovich et al. , 1996). Taken together, these
studies show that immunzation with peptide-pulsed DCs can lead to potent anti-tuor
responses. In addition, they suggest a role for antigen source and APC type in the
initiation of T cell responses.
A role for peptide-pulsed DCs in the induction of viral immunty has also been
demonstrated. Studies using hepatitis B surface antigen paricle-pulsed DCs transferred
into syngeneic hosts demonstrated a role for DCs in the priming of CTL against hepatitis
B proteins (Bohm et aI. , 1995). The authors also demonstrated that although CTL
generation was suppressed in carageenan-treated mice, which eliminates both M~s and
DCs, CTL activity was not suppressed in mice treated with dichloromethylene-
diphosphonate liposomes, which would only eliminate M~s (Bohm et aI., 1995). It was
fuer demonstrated that CTL responses could be restored by the injection of peptide-
pulsed M~s in carageenan-treated animals. Ludewig et ai. used DCs pulsed with the
immunodominant epitope from LCMV' s glycoprotein in vitro or DCs that constitutively
express the same epitope to immunize mice (Ludewig et aI. , 1998). These authors
demonstrated that mice immunzed intravenously with either group of DCs were
completely protected from a lethal LCMV challenge. In addition, splenocytes from these
mice displayed direct ex vivo cytotoxicity against peptide-pulsed tagets by day four. The
immunzed mice were protected from day two til day 60 from infections in which
homing of T cells into peripheral organs is critical for viral clearance. These data suggest
that immunzation by peptide-pulsed tagets offers long lasting viral immunty (Ludewig
et aI., 1998). Although these studies all suggest that injected DCs effciently prime
strong CD8+ T cell responses that offer protection from viral challenge, a role for host
APC in the observed priming stil canot be excluded.
In Vivo Evidence For The Exclusive Abilty Of DCs To Present Antigen 
CDS T Cells
One recent study took advantage of transgenic animals that express the receptor
for diphtheria toxin under the control of the CD11c promoter. As previously mentioned
many populations ofDCs express the CD11c molecule, whereas M~s and B cells do not.
One caveat worth mentioning is that activated T cells also express CD 11 c. In these mice
the injection of diphtheria toxin eliminates DCs from the anmal. Using this approach
Jung et al. demonstrated that injection of diphtheria toxin blocked the generation of CTLs
to some antigens, e.
g. 
Listeria monocytogenes and Plasmodium yoeli (Jung et aI. , 2002).
Another caveat in this study was the possibilty that the ability of M~s to stimulate T
cells was impaired by the toxin, e.g. when M~s ingested the toxin durng phagocytosis of
dying DCs. These data are among the strongest to show that DCs can play an essential
role in stimulating T cell responses at least for certn antigens. However, whether this
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is tre for other antigens is unown; in vivo some antigens may be preferentially
presented on DCs while others are also presented on M~s. It is also interesting to note
that the two pathogens chosen by the authors rely heavily on cross-presentation for
protective immunity (Lenz et aI. , 2000; Shen et aI. , 1998).
In a set of experiments designed to visualize the APCs that interacted with naive
T cells in situ Norbur et al. infected mice with a vaccinia virus expressing EGFP and
could detect infected (EGFP-expressing) DCs and M~s in situ. When they transferred
CFSE-dye-Iabeled virus specific T cells, they observed clustering of these CD8+ T cells
around EGFP-positive (infected) APe. Although M~s made up :; 60% of infected cells
clustering was observed only around the infected DCs. This observation was interpreted
to show that only DCs were stimulating the T cells however T cell stimulation was being
inferred, and what was actually measured, T cell-APC clustering, is infuenced by
strength of adhesion, chemokies and potentially other factors. In fact, DCs can cause T
cells to cluster, even in the absence of specific antigen (Inaba and Steinman, 1986). This
analysis would fail to detect single T cells that were stimulated and lor ones that detached
from an APe. Moreover, a substatial component of the T cell response to vaccinia
virs occurs through cross-priming (Norbur et aI. , 2001; Sigal et al. , 1999) and the
APCs involved in this process would not express EGFP from the vaccina recombinants.
These data clearly demonstrate that DCs can and do present antigens to naive T cells, but
a role for M~s in antigen presentation stil canot be definitively ruled out.
Changes in MHC Class I Processing and Presentation in Mature DCs
Very little is known about the changes in MHC Class I upon dendritic cell
matuation. Taking advantage of the ability of the phagocytosis of bacteria by DCs to
induce both functional and phenotypic matuation, Rescigno et al. demonstrated that
MHC class II molecules were up regulated with faster kinetics (within 1 hour) than class
I molecules. Using 14 day-old bone marow-derived DCs from mice, Rescigno et al.
have shown both an increase in Class I synthesis as well as a 3-fold increase (from 3 to 9
hours) in stability of newly synthesized molecules after an 18-hour incubation with
Streptococcus gordonii. Since bacteria uptae was used in this study, these experiments
demonstrate a role for dendrtic cell matuation in stabilzation of class I molecules
loaded with exogenous antigen (Rescigno et aI. , 1998). It is also known that the
proteosome subunits, MECL- , LMP2, LMP7 , P A28a and P A28f3 are up regulated
durng DCs matuation. These changes in the proteosome could result in the generation
of different peptides upon antigen processing (Macagno et aI. , 1999; Macagno et aI.
2001).
A recent paper from Delamare et ai. demonstrated that LPS-activated DCs
increase their surace MHC I by 7-fold with in 30 hours. This group went on to show
that, unlike MHC II complexes, MHC I complexes are not sequestered in immatue DCs.
Pulse chase experiments demonstrated a 2.6 fold increase in heavy chain synthesis in
mature DCs when compared to immatue DCs. The same 2.6 fold increase was observed
for heavy chain-f32m complexes when measured by immunoprecipitation. After 15
minutes, the assembly of the complexes was only slightly more effcient in matue DCs
than in immatue DCs. Although the kinetics of complex transport to the cell surface was
nearly equal in the two cell types, MHC I complexes were slightly less stable on the
surace of immatue DCs. These data indicate that the observed higher levels ofMHC I
on maturng DCs is due to new protein synthesis and not assembly and recruitment
(Delamare et aI., 2003)
Control Of Cross-Presentation During DC Maturation
Recent evidence suggests that the ability of DCs to cross-present exogenous
antigen on Class I is also developmentally regulated. Using ovalbumin (OV A)-pulsed
LPS-stimulated DCs Delamare et al. demonstrated that cross-presentation of OVA
occurs though the classical TAP-dependent pathway. To fuher support the idea that
OV A gains entry to the cytoplasm in these experients, these authors used FITC
conjugated to OVA. Using immunofluorescent microscopy, they were able to
demonstrate the presence of FITC-OV A in the cytoplasm withi 30 minutes of
phagocytosis, but before matuation was complete. The presence of OV A in cytosolic
fractions was also confirmed by Western blot analysis. This group also demonstrated that
although immatue DCs could form the MHC I-OVA complexes, they could not cross-
present antigen to CD8+ transgenic OT-I T cells (specific for the immunodominant OVA
epitope SIINFEKL) suggesting there are addition steps necessar for cross-presentation
to be possible. In addition, only DCs matued through cluster disruption and LPS
stimulation or CD40 ligation were able to crOss-present OV A to the T cells, thus
dendritic cell matuation is necessar, but not suffcient for cross-presentation to occur.
By looking at the time course of cross-presentation ability, these authors showed that
unlike endogenously synthesized antigens destined for class I presentation, antigen
destined for cross-presentation are sequestered (possibly in the endoplasmic reticulum) in
the immatue DCs. By sequestering antigens in this maner, access to the proteosome is
denied til full dendritic cell matuation occurs. Taken together these data suggest that
the signals necessar for classical MHC I presentation, MHC II presentation and cross-
presentation are all developmentally regulated, but are stil distinct (Cella et aI. , 1997b).
In a more recent study, Gil- T orregrosa et al. investigated the effect of dendritic
cell matuation on cross-presentation that was mediated by Fcy expression by bone
marow-derived DCs. They found that the ability to cross-present antigen by these cells
was possible during a very narrow window of development. Using LPS stimulation and
immune complexed OVA antigen, it was shown that only intermediate DCs being able to
cross-present antigen to the CD8+ restricted T cells. These authors fuher demonstrated
that intermediate cells were able to internalize antigen better than immatue or matue
DCs. LPS stimulation led to additional changes in the class I pathway of these DCs.
Changes in proteosome subunts composition as well as changes in the rate of T AP-
translocation were also observed in matung DCs. Since introduction of antigen directly
into the cytosol corrected the cross-presentation deficiencies in matue and immatue
DCs it was suggested that another post-endocytic event regulated by matuation must be
involved in cross-presentation (Gil- Torregrosa et aI. , 2004).
Changes In MHC II Antigen Processing And Presentation in Mature
Dendritic Cells
In addition to the normal intracellular endocytosis and exocytosis machinery
professional APCs, such as DCs, contain specialized comparments for MHC Class II
antigen processing and presentation. Immatue DCs contan many vacuoles expressing
late endosome/lysosomal markers (LAMP , 19p, hydrolases and low pH), which contain
class II molecules and H-2M. H-2M' s role in MHC II loading is to aid in the exchange
of CLIP for higher affinity peptides. Once antigen is acquired, the DC changes it
phenotype to that of an intermediate DC. In intermediate DCs, the MIIC comparments
are replaced by the nonlysosomal vacuoles, CIIV , which now localize to the microtubule
center (Mellman et aI., 1998). The CIIV comparment no longer expresses lysosomal
markers. The matuation ofDCs also involves a series of intracellular changes involving
MHC II molecules. The vacuoles containig the loaded MHC II molecules move to the
surface of the DC and are displayed on the plasma membrane (Mellman et aI. , 1998).
These changes in class II traffcking are thought to result in a type of antigenic memory
such that the DC wil be able to present the antigens it encountered as an immatue cell.
These changes also result in changes in trafficking that lead to waves of high level
expression ofMHC II-peptide complexes on the surace ofthe DCs, allowing the DCs to
better stimulate CD4 + T cells.
The changes in MHC II traffcking are also accompaned by biochemical changes
in the stability of class II molecules. In immatue DCs, class II molecules are unstable
with a half-life of 12 hrs before they are tageted to the lysosomes and degraded. This
degradation is independent of peptide loading. On the other hand, class II complexes in
matue DCs have a half-life of ::50 hours and are targeted from trans-golgi network to the
plasma membrane (Mellman et aI. , 1998). Another matuation induced biochemical
change may involve regulation of the cysteine protease Cathepsin S (cat S) by an
antiprotease cystatin c. Cat S plays a role in the cleavage of the invarant chain durng
MHC II assembly. Cystatin c s role is to attenuate the protease activity of cat S and slow
down invariant chain processing, resulting in the transport of the class II molecules to the
lysosomes. In immatue DCs there is enough cystatin present to perform this inhbitory
fuction. Upon DC matuation, the levels of cystatin are decreased, thus increasing the
active levels of cat S in the mature cells. Ths increase in cat S activity, results in the
newly formed class II molecules avoiding the lysosomal degradation and thereby
reaching the plasma membrane (Mawhorter et aI. , 1994). Recently, EI-Sukar et al.
have knocked out cystatin in mice. The resulting characterization of the DC phenotype in
these cystatin-deficient mice has shown no effect on the expression, sub-cellular
localization, formation of peptide-loaded class II complexes or the efficiency of
exogenous antigen processing (EI-Sukari et aI. , 2003).
The Role Of DCs In The Induction And Maintenance Of Peripheral
Tolerance
Although CD8+ and CD8- DCs are able to present antigen and activate T cells to
enter into cell cycle, it has also been shown that CD8+ DCs are less efficient at priming
allogenic CD4+ and CD8+ T cells. In the case of CD8+ T cells, the T cells stimulated by
CD8+ DCs do not make enough IL-2 to sustain their proliferation and become anergic
(Kronin et aI. , 1996), whereas CD4+ T cells primed by CD8+ DCs die by a Fas/FasL
mechansm (Suss and Shortman, 1996). Ths led to the hypothesis that CD8+ DCs may
be the cells responsible for maintenance of self-tolerance. Belz et al. have shown that
CD8+ CD11 b- DCs are involved in the induction of self-tolerance to tissue-associated
antigen. Using mice transgenic for yellow fluorescent protein and a herpes simplex
protein gB 498-505, these investigators were able to show by antibody depletion stdies that
only the CD8+ DCs were able to induce production of f3-galactosidase in a hybridoma cell
line specific for herpes virus gB 498-505 and therefore were responsible for the tolerization
of the antigen specific T cells (Belz et aI. , 2002a). On the other hand, this same group
recently demonstrated the importce of CD8+ dendritic population in the priming of
CTL immunty to subcutaeous herpes virus infection as well as other viruses (Belz et aI.
2004). Others have shown that the population ofDCs responsible for presenting soluble
antigen to T cells depends on the type ofT cells. Using soluble OVA, Pooley et al.
demonstrated that CD8- DCs are more efficient at presenting OV A to CD4+ T cells
whereas CD8+ DCs are better at presenting soluble antigen to CD8+ T cells (Pooley et aI.
2001). In agreement with Beltz et al. this group concludes that CD8+ DCs are critical in
cross-presentation (Belz et aI. , 2002b; Pooley et aI., 2001). Due to the confsion in
precisely typing DC, whether the CD8a + DC involved in intiating the antiviral responses
is the same as the CD8a + population involved in tolerance induction is yet to be
determined. It is possible that fuher subsets of this very heterogeneous population of
cells are yet to be elucidated. It is also possible that the infamatory environment
determines whether a DC is immunogenic or toleragenic and not the DC' s lineage.
Others have proposed that the matuation state of the DC is what determines
whether T cells are activated or tolerized. There are two ways in which T cell
interactions with immatue DCs could lead to tolerance induction. One possibility is that
immatue DCs will present low levels ofpeptide-MHC complexes without a
co stimulatory signal to the encountered T cells thus resulting in the T cells becoming
anergic. Another sitution that might result in tolerance is that intermediately mature
DCs present antigen in the absence of infamatory cytokines (Lutz and Schuler, 2002;
Wilson and O'Neil, 2003). Other groups have shown that imunzation with peptide-
pulsed immatue DCs inhbits effector T cell fuction (Dhodapkar et aI. , 2001). This
same group went on to show that the peptide-pulsed imatue DCs led to the induction
of antigen specific CD8+ regulatory T cells (Dhodapkar and Steinman, 2002). Regulatory
T cells have been shown to be importt in autoimmunty and tolerance. It has also been
shown that DC matuation is importt for cross tolerization of CD8+ T cells (Albert et
aI., 2001). But like all thngs with this heterogeneous population of cells, matuation
state alone may not be all that dictates which way the immunty versus tolerance scale is
tipped. Menges et al. have demonstrated that repeated injections ofTNF-a-matued DCs
can lead to antigen specific protection of mice from recurng EAE (experiental
autoimmune encephalomyelitis (Menges et aI. , 2002).
Macrophages
M~s also arise from a bone marow precursor and can be grown in vitro 
placing BM progenitors in macrophage colony stimulating factor (M-CSF). M~s exist in
various forms in virtally every tissue in the body including secondar lymph organs like
lymph nodes and spleen (Morrssette et aI. , 1999). Monocytes leave the bone marow
and enter the tissues via the blood stream. In some tissues, M~s differentiate into
specialized cells such as Kupffer cells in the liver or microglia cells in the brain. 
become fully fuctional M~s need to receive matuation signals such as cytokine tuor
necrosis factor (TNF-a), LPS or interferon -yo M~s, like DCs, express MHC I , MHC
Class CD 11 b, CD80 and CD86. Upon activation by infamatory cytokies
CD40/CD40L interactions, B7/CD28 interactions or Toll receptors, the levels of all of
these molecules are up regulated. M~s are also able to migrate into the T cell area in the
lymph nodes. In addition to all of these featues, M~s are highly phagocytic makng
them a good cell type to acquire foreign antigens and present them to T cells.
In vitro Evidence For A Role For Macrophages In The Initiation T cell
Responses
Much evidence has accumulated supporting a role for M~s in stimulation ofT
cell responses in vitro. Studies designed to determne the APC involved in presenting
chemically modified allergens to CD4+ T cells, showed that both M~s and DCs, but not
B cells were able to present these antigens to CD4+ T cells clones isolated from allergic
patients. These studies also showed that both M~s and DCs could restimulate ThO, Th1
and Th2 clones (KaWert et aI. , 2000).
Since many human viral pathogens have gene products that can interfere with
antigen processing and presentation, thereby allowing the virus to escape detection by the
immune system, it may be critical to have numerous cell types capable of priming T cell
responses. One such virus, cytomegaloviru (CMV), a f3 herpes virus, infects many cell
types in vivo including M~s and DCs. The priming of CD8+ T cells and the generation of
cytotoxic T cells are importt for CMV clearance. CMV encodes two proteins that
interfere with class I expression. One of these proteins causes it to be retaied in the ER-
golgi and the other protein binds and sequesters f32-microglobulin. It has recently been
shown that these immune invasion genes are unable to down regulate class I in infected
M~s cell lines as well as in primar M~s, allowing these cell to present class I restricted
epitopes to CTLs. The authors conclude that M~s playa critical role in the priming and
maintenance of high precursor frequency in CMV (Hengel et al. , 2000).
In vitro Evidence For A Role For Macrophages In Cross-presentation
As previously discussed, one characteristic that distinguishes professional antigen
presenting cells from the non-professionals is the abilty to cross-present soluble antigen
on MHC I molecules to CD8+ restricted T cells. Abundant literatue exists on the ability
of M~s to present exogenous antigen to CD8+ T cells (Brut et al. , 1990; Kapsenberg et
aI. , 1986; Kovacsovics-Banowski et aI. , 1993; Rock et aI. , 1993; Weinberg and Unanue
1981). Using Listeria Brut et aI. demonstrated that M~s infected with the intracellular
bacteria could present antigen to CD8+ T cells. The ability of M~s to cross-present
bacterial antigens was shown to be dependent on the growth of the bacteria and
expression of hemolysin by the bacteria Listeria monocytogenes (Brut et aI. , 1990). In
studies using OVA-specific T cell hybridomas, Rock et al. demonstrated that splenic and
peritoneal M~s can cross-present soluble ovalbumin to T cells hybridomas. Although
the abilty ofDCs to cross-present exogenous antigen in association with class I could not
be ruled out by these experiments, a role for B cells could be (Rock et aI., 1993). In 
later paper, ths group also demonstrated that peritoneal M~s and M~ clones could also
cross-present antigens (Kovacsovics-Banowski and Rock, 1994). In addition
Kapsenberg et aZ. demonstrated using OVA-specific hybridomas that although both DCs
and M~s could cross-present soluble antigen to B cell depleted splenocytes, only M~s
could cross-present insoluble antigens (Kapsenberg et aI. , 1986).
In vivo Evidence For A Macrophages Role In The Initiation Of Immune
Responses
Early studies had demonstrated that imunzation with M~s led to the priming of
naive T cell responses (Askonas et aI. , 1968; Unanue and Askonas, 1968). However, in
these experiments M~s may not be directly priming T cells because it is now known that
DCs can acquire and cross-present antigen from other cells.
The role of M~s in acquiring and presenting antigen to T cells has been
demonstrated in viral models. By sorting APCs by F ACS from the lymph nodes and
spleens of Sendai virus infected mice, Usherwood et aZ. demonstrated that both M~s and
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DCs, but not B cells were able to present antigen to Senadai specific CD4+ and CDS+ T
cell hybridomas in vitro (Usherwood et aI., 1999). Hamlton-Easton et al. obtained
similar results in an infuenza mouse model. M~s and DCs from mice infected with
infuenza were able to present antigen to virus specific MHC I restricted T cell
hybridomas (Hamilton-Easton and Eichelberger, 1995).
A number of studies have attempted to deplete M~s in vivo to determine the
effect of depletion on T cell priming. Using carageenin and silica to deplete animals of
phagocytic cells, numerous groups demonstrated the necessity for M~s in the initiation
of T cell responses. Debrick et al. studied the abilty of silca carageenin depleted
anmals to mount CD4+ and CD8+ responses against infuenza virus. Although CD4
proliferative responses to live virus were unaffected by silca treatment, CTL responses to
the virus were completely abolished. One caveat of these experiments is the use of silica
to deplete M~s because it is possible for the silca to damage the higWy phagocytic
immatue DCs in the same anmal. However in Debrick' s study in similarly treated
animals, injection of peritoneal M~s was able to completely restore CTL responses in
these animals. To rule out the possibilty of a containating cell type being responsible
for the rescued CTL responses in these animals, these authors demonstrated the abilty of
a M~ cell line to restore CTL responses. These data strongly suggest M~s are suffcient
for the generation of CTL responses to infuenz (Debrick et aI. , 1991).
In similar experiments designed to investigate the mechanism of adjuvant activity,
Wu et al. also showed the dependence of CTL generation on the presence of fuctional
M~s. These authors showed that macrophage depletion by silica carageeni treatment
had little effect (not statistically significant) on CD4+ T cell proliferative responses or
antibody titers, but drastically reduced CTL activity in anmals imunized with soluble
OVA and QS-21 (an adjuvant). The major flaw in depletion experiments using silica
and carageenin is the ability of these treatments to damage the highly phagocytic
immatue DCs population in the same anmal. However these authors went on to
demonstrate that cultured splenic M~s, but not DCs could reconstitute the CTL
responses to almost normal levels (Wu et aI. , 1994).
In the study discussed above using exogenous hepatitis B surace antigen
(HBsAg) paricles pulsed APCs, Bohm et al. also demonstrated that BM-derived and
peritoneal M~s could induce hepatitis specific CTL. Although elimination of M~s and
not DCs stil resulted in CTL priming, elimination of both cell types by treatment with
carrageenan suppressed CTL generation. Additionally in the carageenan treated
anmals, CTL activity could be restored by immunzation with HBsAg pulsed BM-
derived M~s (Bohm et aI. , 1995).
Another way to delete these highly phagocytic cells is though the administration
of toxic liposomes. In studies using liposomes made from dichloromethylene
diphosphonate, which is toxic for M~s, Ciavara et at. demonstrated that splenic red pulp
M~s are important for the initiation of both CD4+ and CD8+ T cell immunty against
vesticular stomatitis virus. Interestingly, these authors also demonstrated that the toxic
liposomes had no effect the abilty of splenic APCs to stimulate mixed lymphocyte
responses, suggesting the liposomes were not toxic to splenic DCs. These experiments
suggest M~s were sufficient to prime the VSV response (Ciavara et aI. , 1997). Taken
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together the silicalcarageenin and toxic liposome experiments suggest that phagocytic
cells are critical for the initiation of CTL responses, but the true identity of the antigen
presenting cells in these studies stil has not been elucidated.
Priming Of Naive T Cells
The predominant idea in the literatue is that professional bone marow-derived
APCs are needed for the initiation of immune responses (Lenz et aI. , 2000; Sigal et aI.
1999; Sigal and Rock, 2000). Cells of non-hematopoietic origin are thought to be unable
to prime naive T cell responses, because they lack the necessary co stimulatory molecules
and are unable to traffic to lymphoid organs. The need for the abilty of a cell to migrate
into the lymph node being necessar for a cell to fuction as an APC is supported by the
fact that fibroblasts can initiate immune responses when delivered interperitoneally or
directly into the spleen (Kundig et aI. , 1995). Kundig et al. interpreted these data to
mean that a good APC doesn t need costimulatory molecules or the ability to secrete
cytokines, but only the abilty to home to lymphoid organs where T cells congregate.
Using various model systems, this group ruled out the role of cross-presentation on the
observed results (Kundig et aI. , 1995). A novel cell termed fibrocyte found in humans
and mice, a fibroblast-like cell that are collagen /CD13 /CD34 /CD45 , that can present
antigen to naive T cells in vitro and in vivo. These cells have been shown to home to the
site of a wound in response to CCR7 and are thought to playa role in wound healing and
tissue repair (Abe et aI. , 2001). These cells also express class CD80, CD86 and
adhesion molecules (CD 11 a and CD54) that are needed for antigen presentation. 
addition fibrocytes were able to home to the draining lymph node when injected
subcutaneously. It has also been shown that HIV gp120 pulsed mouse fibrocytes were
able to prime naive CD4+ T cell in vivo (Chesney et al. , 1997). Since these cells have
class II on their surace, they wil probably tu out to be a professional APCs. If these
other cell types playa role in priming naive T cells in vivo their role is a minor one. The
bone marow chimera data presented in this thesis as well as other studies in the literatue
underscore the importce and necessity of bone marow- derived APCs in the initiation
of immune responses (Lenz et aI., 2000; Sigal et aI., 1999; Sigal and Rock, 2000).
Costimulaton And Naive T Cell Priming
Efficient T cell primng requires interactions between the T cell and the antigen-
presenting cell. The first interaction, signal 1 , is the interaction of the T cell receptor
with the peptide -MHC complex on the antigen-presenting cell. The second interaction
(signal 2) involves the interaction ofB7 on the APC with its receptor CD28 present on
the T cell. The costimulatory signal is required for the optimal induction of IL-2 as well
as the induction of the expression of the high affnity receptor for IL-2. The two signal
hypothesis has been used to explain the need for both peptide-MHC/TCR interactions and
co stimulatory interaction for the initiation of naive T cell responses (Janeway, 1989;
Laffert and Woolnough, 1977; Mueller et aI. , 1989). Evidence exists that many
molecules can serve to deliver the co stimulatory signal to naive T cells. The list of
molecules able to act as the co stimulatory signal includes, but is not limited to CD40
OX40 , LFA- , ICAM- , 4BB1 , B7. 1 and B7.
B7-CD28 interactions
The best-characterized costimulatory interaction involves B7's interaction with its
receptor CD28. Over the last 10 years evidence has accumulated for the B7/CD28
interaction being the critical co stimulatory interaction (Boussiotis et aI. , 1996; Van Gool
et aI. , 1996). It has also been shown that TCR engagement the absence of B7 or CD28
signal (either by blockade or genetic knockout) leads to T cell anergy or
nonresponsiveness (Boussiotis et aI. , 1996; Boussiotis et aI. , 1994; Guinan et aI. , 1994).
A major difference in the priming of naIve CD4+ T cells versus naive CD8+ T cells
seems to be in the dependence on the need for co stimulation at least in the response to
viral pathogens. Using lymphocytic choriomeningitis virus (LCMV) and mice mutat in
one costimulatory molecule as a model, it has been shown that the CD8+ T cell response
is stil induced in CD40L, OX-40 and CD28 deficient mice. In this same model, the
ability ofCD4+ T cells to mount an antiviral response was severely diminished. When
41 BB knockout mice were infected with LCMV, the opposite pattern was observed, in
that CD8+ T cell responses were mildly compromised and CD4+ T cells responses were
unaffected (Seder and Ahmed, 2003; Whtmire and Ahed, 2000). Others have
demonstrated a need for costimulation in the generation of CTL responses to other
viruses. Using vaccinia virus and exogenous ovalbumn as a model, Sigal et aZ.
demonstrated a critical role for B7/CD28 costimulation is the generation ofCD8+ T cell
responses (Sigal et aI. , 1998). Par of the role of costimulation may be able to be
overcome by high dose antigen at least for CD8+ alloresponses. Cai et af. demonstrated
that although low level antigen stimulation required costimulation for the proliferative
response , high level antigen did not. These authors also showed that costimulation plays
a role in lengtening the response by increasing IL-2 secretion (Cai and Sprent, 1996). In
contrast, co stimulation ofCD4+ with ICAM- 1 in the absence ofB7-CD28 interactions
leads to functional anergy of the naive T cells (Ragazo et aI. , 2001). These authors also
demonstrated that stimulation of DO 11. 1 0 CD4 + T cells with APCs that expressed
ICAM- 1 as well as B7.21ed to a decreased secretion ofIL-4 by the proliferating T cells
(Ragazo et aI. , 2001).
Molecules other than B7 and ICAM-l, such as CD40 , OX- , 41BB , or LFA-
can also serve as the 2 signal for T cell activation (Damle et aI. , 1992; Evans et aI.
2000; Seder and Ahed, 2003; Shide et aI. , 1996; Whitmire and Ahed, 2000). An
important role for CD40-CD40L in initiation of both T and B cell responses has been
demonstrated. Although, CD40L is not essential for T cell responses if the APC
expresses co stimulatory molecules, it is necessar for T cells to induce the expression of
co stimulatory molecules. It was also demonstrated that CD40 ligation led to the up-
regulation of ICAM- 1 and that proliferation ofT cells in CD28 deficient mice is more
dependent on ICAM-1 (Shinde et aI. , 1996). Naive B cells when used as antigen
presenters usually lead to the tolerization of T cells. CD40 ligation on B cells leads to the
up-regulation of the B7s and ICAMs, leading to the conversion of the B cell to a
competent APC (Evans et al. , 2000).
The Role Of Costimulation In Boosting Responses and in the Stimulation 
Memory T Cells
Although the majority of evidence has demonstrated an important role for the
B7/CD28 or B7/CTLA-4 interaction as being an important signal of the priming ofT
cells, there is evidence for other molecules serving the co stimulatory signal. Using mice
deficient in CD28 or mice deficient in heat stable antigen (HSA), Liu et al. demonstrated
a critical role for CD28 in the priming of naive effector CTLs in an inuenz model (Liu
et aI., 1997). Using mice 8 days after infuenz infection and taking advantage of the
availability of antibodies against B7. 1 and B7. , this group fuher demonstrated in the
HSA knockout anal, a requirement for either HSA or B7.1/B7.2 in the priming of a
recall response. When these experiments were repeated, using mice 100 days after
priming, similar results were obtained demonstrating that although HSA or CD28 can
provide the necessar costimulation for memory induction, the B7-CD28 co stimulatory
signal is necessar for the induction of effector fuction from the memory T cells (Liu et
aI., 1997).
Effector T cells
As previously described naive T cells need to receive a good quality signal from
the APC. Three thigs contribute to ths quality signal: the concentration of peptide-
MHC complexes, the levels of co stimulatory molecules and the duration of APC- T cell
cognation (Lanavecchia and Sallusto, 2002). It has been shown in CD4+ T cells that
there are different levels ofTCR signaling needed for naive CD4+ T cells to acquire
different effector fuctions. A low strength signal will induce proliferation and the
ability to home to the lymph nodes, but not effector fuction. A medium strengt
signaling will induce and cytokine exposure will stimulate Th1 or Th effector
differentiation and the T cells gain the expression of adhesion molecules necessary for
migration into peripheral tissues. Really high levels of antigenic stimulation wil lead to
T cell death via AICD. This hierarchy of antigenic signal determining T cell fate has
been termed the progressive differentiation model by Lanavecchia (Lanavecchia and
Sallusto, 2002). Others have shown that even a limited exposure to antigen causes both
CD4+ and CD8+ T cells to undergo an antigen independent program of proliferation and
differentiation (Masopust et aI. , 2004; Seder and Ahed, 2003; van Stipdonk et al. , 2003;
van Stipdonk et al. , 2001).
The commtment of naive T cells to the proliferation program can occur in as little
as 6 hours if there is high dose antigen and high level stimulation (Masopust et aI. , 2004).
On the other hand, the length of stimulation needed to commit naive T cells to the
proliferation program for low dose antigen and low level costimulation can be as long as
40 hours (Lanvecchia and Sallusto, 2002). After a naive T cell encounters antigen it
wil proliferate and differentiate into an effector cell. Once activated, the T cell will sta
a new transcriptional program that wil express genes involved in cell cycle, cytokines
and cytokine receptor genes, adhesion molecule genes involved in homing and finally
genes involved sensitivity to activation induced cell death (AICD) (Lanavecchia and
Sallusto, 2002). Both naive CD4+ and CD8+ express next to no mRA for the varous
effector molecules they wil need to express. The expression of these molecules involves
a lot of signaling molecules and intracellular events. The effect of this priming and the
steps needed for a T cell to differentiate into a effector and then on to a memory T cell
are different for the CD4+ and CD8+ subsets (Masopust et aI., 2004; Seder and Ahed
2003).
CD8+ T cells require a very short time for antigen exposure to become committed
to rapidly enter division and undergo a very rapid proliferation program (6-8 divisions a
day) (Kaech and Ahed, 2001; Mercado et aI. , 2000; van Stipdonk et aI. , 2003; van
Stipdonk et aI. , 2001). CD4+ cells do not have this dynamic programng and require
prolonged antigen exposure to proliferate (Foulds et aI., 2002). CD8+ T cells are also
able to develop into effector cells faster than CD4+ T cells. This has been demonstrated
using adoptive transfer of ovalbumin (OVA) specific CD4+ and CD8+ T cells into wild
type mice that were then infected with a recombinant Listeria monocytogenes
intracellular bacterium, which expresses OV A. In ths model 8 days after inection :;85%
ofCD8+ T cells had become effectors as determined by IFN-y staining, whereas only
7% of CD4+ T cells stained for the effector cytokie (Foulds et aI., 2002). Ths abilty
ofCD8+ T cells to expand significantly better than CD4+ T cells holds tre in other viral
models as well, including Sendai (Cauley et aI. , 2002), LCMV (Homan et aI. , 2001) and
vaccinia virus (Harington et aI. , 2002) infection in mice and Epstein-Bar virus infection
in humans (Maini et aI. , 2000). The same trend has been shown for the predominance of
CD8+ T cells in the response to Listeria. However, there are other models of infection
where more CD4+ T cells go on to become IFN-y secreting effector cells i. e. Leishmania
major (Belkaid et aI. , 2002; Mendez et al. , 2001) and Mycobacterium tuberculosis (Lima
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et aI. , 2001; Silva et aI. , 1999; Winslow et aI. , 2003). It is interesting to note that these
differences could also be explained by differences in the ability of the various antigens to
be presented as well as the ability of the pathogen to directly infect professional APCs.
CDS+ Effector T Cells
Once stimulated the effector molecules produced by CD4+ and CD8+ T cells
differ. In the case ofCD8+ T cells the major effector cytokines are TNF-a and IFN-
Cytotoxic T cells (CTL) recognize abnormal cells by detecting antigenic peptides bound
to the target' s MHC class I molecules. In addition to those two cytokines, CD8+ CTL
also produce molecules needed to induce apoptosis in their targets. Once the taget cell is
recognized, the CTLs wil kill them by FasL induced ligation ofFas or the secretion of
perf orin and granme B (Henkar, 1994; Henkar and Sitkovsky, 1994). The peptides
displayed on MHC class I molecules of most cells are generated from the genes being
expressed within that cell. Consequently, infected cells wil display peptides from
intracellular pathogens and cancerous cells wil present peptides from abnonnally
expressed genes. Effector CTLs circulate looking for cells expressing such foreign
peptides and eliminate them. CTL can also be broken down into subsets. There are Tc1
and Tc2 CD8+ T cells. Tc1 cells express the chemokine receptor CCR5 and Tc2 cells
express the chemokine receptor CCR4. Both subsets of CD8+ cells have cytolytic
capability. The cytokine environment can also effect CD8+ T cells development.
Cytokies like IL-2 and IL-15 promote CD8+ T cell differentiation (Lanavecchia and
Sallusto, 2002). There is also evidence for a role in inhbition of T cell responses by
cytokines, such as transforming growth factor f3.
CD4 Effector T Cells
CD4+ T cells are generated by the presentation of antigenic peptides on MHC
class II molecules. The main fuction ofCD4+ T cells is the secretion of varous helper
cytokines that aid in the development of the various other immune cells. Effector CD4
T cells can be broken down further into 3 subsets ThO , Th1 and Th. ThO cells are
thought to be the least differentiated and express predominantly interleukn-2 (IL-2), and
granulocyte macrophage colony stimulating factor (GM-CSF). Th1 cells predominantly
produce IFN-y. IFN-y activates M~s to produce varous cytokines as well as generate
oxygen intermediates importt for their microbicidal fuction. Th1 cells can also
secrete IL- , TNF-a and lymphotoxin. These cytokines playa key role in the elimination
of intracellular pathogens, M~ activation and delayed type hypersensitivity responses.
Th2 T cells secrete interleukin-4 (IL-4), IL-5, IL- , IL- 10 and IL- 13. These cytokines are
important for B cell activation and isotype switching as well as allergic responses. It has
also been recently shown that many genes are differentially expressed by the subsets.
These include surace markers as well as chemokines. Th1 cells preferentially express
IFN-y receptor- f3 chain, interleukn- 12 receptor chain, interleukn- 18 receptor, P-
selectin glycoprotein- , CXCR3 and CCR5. Where as Th cells preferentially express
the IL- like molecule TlIST2 , CCR3 , CCR4 and CCR8. This difference in the ability
to produce the various cytokines is regulated at the level of transcription factors. Th1
cells express the transcription factor T -bet, where as Th2 cells express the transcription
factor gata-3 and c-Maf(Glimcher and Murhy, 2000). Cytokines also have an important
role in both CD4 T cell subset differentiation. IL-4 stimulation of ThO cells induces the
expression of the transcription factors Gata-3 and c-Maf, which in tu induces Th2
specific genes in CD4+ T cells. On the other hand , if the CD4+ T cell is exposed to IL-
it wil express the transcription factor t-bet and develop into a Th1 type cell (Glimcher
and Murphy, 2000; Lanavecchia and Sallusto, 2002). There is also evidence that high
TCR signal strength of TCR can cause up regulation of T -bet and GAT A 3 , suggesting
that skewing of CD4+ T cell differentiation, can occur in the absence of cytokines. It is
known that Il- 12 is important in the stimulation of ThO cells to become Th1 cells and that
IL-4 is important for the differentiation of ThO cells into Th2 cells.
What other factors contribute to the polarzation of CD4+ T cells into the two
subsets is stil an area of very active investigation. Recent evidence has demonstrated a
role for the stimulating APC. Some groups have shown that CD8a + DCs produce IL-
and preferentially stimulate CD4+ T cells to become Th1 cells (Glimcher and Murhy,
2000). It has also been demonstrated that myeloid DCs lead to the development of Th2
cells possibly by the secretion of IL-6 (Diehl and Ricon, 2002). There has also been
data suggesting a role for antigen dose and structue. Experiments involving the use of
altered peptide ligands have demonstrated a role for strengt of TCR signal in
determing lineage commtment (Glimcher and Murhy, 2000).
Whether an anmal responds with a Th1 or Th2 slanted response has been shown
to be important in various disease models. In the case of intracellular parasites like
Leishmania donovani a Th1 response is needed for clearance. The CD4+ cells secrete
interferon-y, which activates the bactericidal mechansms ofM~s to clear the parasite. In
the case of helminth infections like Schistosoma mansoni Th2 responses are correlated
with worm clearance. This is because antibodies play an importt role in the resolution
of helminth infections.
What factors play roles in Th1 versus Th2 CD4+ T cell development in vivo are
stil an unown. One factor that may playa role is the nature of the priming APC. 
experiments using M~s cell lines loaded ex vivo with soluble hemagglutinin, Desmedt 
al. showed that M~s were indeed able to prime CD4+ T cell responses. These authors
fuer demonstrated that this priing was not dependent on host APCs by repeating the
experiments in H-2 mismatched mice. These authors went on to demonstrate that the
majority ofCD4+ T cells primed in these mice were Th1 type cells by ELI SPOT analysis.
This skewing of the CD4+ T cell differentiation was fuer supported by the exclusive
generation of IgG2a and IgG2b in these mice (Desmedt et al. , 1998). Other studies have
also shown differences in CD4 + T cell populations when varous APC are used as
stimulators (Croft et al., 1992. ; Duncan and Swain, 1994)
Other CD4+ T cells can differentiate into suppressor or regulatory T cells.
Regulatory T cells can be fuer broken down in Tr1 and Th3 cells. CD4 CD25+ Tr
cells are importt in the maintenance of tolerance and in suppressing immune responses.
CD4 CD25+ Tr cells arse in the thymus and are self- antigen reactive, where as Trl and
Th3 cells arise in the periphery after antigen stimulation. These cells are known to
secrete IL-10 transforming growth factor-f3 (TGFf3) and IL-4. Tr1 cells secrete IL-
with or without TGF-f3, IL-5 or IL- 13. These cells make little or no B- , IL-4 or IFN-
Th3 cells secrete high levels ofTGF (Mils and McGuirk, 2004).
Activation Induced Cell Death
Due to the possibility of tissue damage inflcted by renegade T cells, the overall
expansion of effector T cells is regulated by many redundant mechansms. After
activation, the expanded T cells wil undergo a contraction, where 90% of the effectors
wil be killed and the suriving T cells will give rise to the memory pool. It is also
known that durng viral inections the CD8+ T cells undergo a more drastic contraction
phase than the CD4+ T cells (Seder and Ahed, 2003). It has been demonstrated durng
viral infections that the magnitude of the T cell response at the peak of the response wil
predict the size of the memory pool (Seder and Ahed, 2003). Some of the molecules
thought to be involved in this process (termed activation induced cell death or AICD) are
Fas/FasL, TNF and its 2 receptors, IFN-y, CTLA-4 and CD40/CD40L (Lenardo et aI.
1999; Seder and Ahed, 2003; Whtmire and Ahed, 2000; Whtmire et aI. , 2000).
There has also been a role demonstrated for the withdrawal ofIL-2 (Blattman et aI.
2003; Seder and Ahed, 2003). CD4+ and CD8+ T cells are susceptible to these
mechansms to varying degrees. The effect of varous death molecules on CD4+ versus
CD8+ T cell homeostasis can be most clearly seen in the Fas-deficient mice, where the
lymphoproliferation ofT cells is predominately in the CD4 comparent (Hildeman et
aI. , 2002). In addition, it has been shown CD8+ T cells are more sensitive to the death
signals transduced through the TNF receptors than are the CD4+ T cells (Speiser et aI.
1996; Syt et aI. , 1996; Zheng et aI. , 1995). Recently a role for perf orin and IFN-y has
been shown for the regulation of effector CD8+ T cells homeostasis (Badovinac et aI.
2000; Kagi et aI. , 1999; Sad et aI. , 1996; Zarozinski et aI. , 2000; Zhou et aI. , 2002).
Memory T cells
The ability of an organsm to generate an effective and stable memory pool may
determine its ability to fight off a secondar infection by the same organsm. It also has
become evident in recent years that a host s repertoire of memory cells and previous
infection history can highly infuence the immune response to a new pathogen (Selin and
Welsh, 2004). The question of how memory T cells arise is stil an open one. Requisite
characteristic of memory T cells are the abilty to stably persist, to rapidly respond to
antigen and the ability to self renew (Wherr et aI., 2003). Curently there are 3 models
proposed by Wherr: the linear model, the decreasing potential model and the
progressive differentiation model. The linear model says that the effector T cells that
surive the contraction phase are destined to become memory T cells. The decreasing
potential model says that once the antigen experienced T cells enter division, one of the
daughter cells form the early division is to become the mother of the memory population
and that the requirements for the generation of effector and memory fuction may be
different (Liu et aI. , 1997). The thrd model put forth by Lanavecchia et al. proposes a
role for the strengt and duration of TCR signaling. Ths model is termed the progressive
differentiation model (Lanzvecchia and Sallusto, 2002). Presently the linear model for
memory generation is the most favored model.
There has been a significant amount of data published in the last five years
supporting the linear differentiation model for memory generation (Opferman et al.
1999:Wherr, 2003 #434; Wherr et aI. , 2003)). Using transgenic T cells specific for the
male H- Y antigen and stimulated with peptide in vitro Opferman et al. showed that it
took 5 divisions for the H- Y T cells to gain effector CTL fuction. By transferrng "pre-
effector" T cells and "post-effector" T cells into congenic naive mice, ths group was able
to demonstrate that only the "post-effector" T cells gave rise to memory cells. They
concluded that although effector CTL are susceptible to AICD , it is this population of
cells that gives rise to long-term memory cells (Opferman et aI. , 1999). Using
lymphocytic choriomenigitis virus (LCMV) and the intracellular pathogen Listeria
monocytogenes Wherr et al. also demonstrated that memory is linear (Wherr et al.
2003).
The literatue has shown that only a few thngs about memory cells can be
generalized because this is a highly heterogeneous population of cells. It has also been
suggested that the generation of memory cells may be different for the different T cell
subsets. Recently there has been a general role demonstrated in the expression of the
chemokies CCR 7 as distinguishing between 2 different types of memory that is
consistent between CD8+ and CD4+ T cells effector memory T cells (T EM) and central
memory T cells (TCM). CCR7 mediates the ability ofT cells to home to the lymph nodes
via the high endothelial venules (Seder and Ahed, 2003; Wherr et aI. , 2003)). It has
been demonstrated that CCR T EM cells found in the nonlymphoid tissues, spleen and
blood are faster at making effector molecules; where as CCR 7+ T EM cells found in the
lymphoid tissues are slower at gaining effector fuctions (Seder and Ahed, 2003;
Wherr et aI., 2003). Both populations of memory cells have been shown to be capable
to eliciting recall responses (Lanavecchia and Sallusto , 2002; Wherr et aI. , 2003). The
question as to whether central memory and effector memory arse from a common
precursor or different stages of differentiation for the same cell remains unesolved. Data
from Wherr et ai. using LCMV has suggested that effector memory cells give rise to
central memory cell (Wherr et aI. , 2003). In contrasting reports, Lanevecchia s group
proposes that central memory cells give rise to effector memory cells (Geginat et aI.
2003a; Geginat et aI., 2003b). And finally, Baron et al. suggests that human effector and
central memory cells may be separate population unable to interconvert (Belz et aI.
2004). These discrepancies in the literatue may be due to the differences between T cell
populations i.e. CD4 versus CD8+ T cells. Another possibilty is that the "rules" are not
the same for viral antigens as they are for antigens generated from intracellular parasites.
It is also importt to note that most of these studies were done using replicating viruses
or intracellular parasites, which would result in high antigenic burdens.
Many papers over the last 5 years have demonstrated that the generation and
persistence of memory cells is not dependent on the presence of antigen. These
experiments have been done by immunizing mice, waiting for them to reach the memory
state than transferrng them into MHC knockout mice (Murali-Krshna et aI. , 1999; Swain
et aI., 1999). This is in shar contrast to naive CD4+ and CD8 T cells, which require
MHC interactions to surive (Ernst et aI. , 1999; Kirberg et aI. , 1997; Kiberg et aI. , 2001;
Takeda et aI. , 1996). A role for IL-7 and IL- 15 in the maintenance of memory has been
established for CD8+ T cells (Marack et aI. , 2000; Sprent and Surh, 2001). Although
MHC class I is not needed for the surival of memory CD8+ T cells, it is necessar for
the adequate expansion and attinment of effector fuction upon challenge (Kassiotis et
aI. , 2002).
Rationale
The predominant view in the literature today is that only DCs efficiently prime
naive T cells responses at least in certain situations (Banchereau and Steinman, 1998;
Guermonprez et aI. , 2002; Jung et aI. , 2002; Norbur et aI. , 2001; Steinman et aI. , 1983;
Steinman and Witmer, 1978). Interestingly, in some studies DCs are the only antigen-
bearng APCs isolated from antigen injected anmals (Jung et aI. , 2002; Norbur et aI.,
2002). Early studies have suggested that M~s could stimulate priar immune
responses, but the curent view is that M~s playa role in immune responses as effector
cells not as the APC initiating the responses.
In vitro there is abundant evidence that M~s can acquire antigen and present it to
CD4+ T cells (Askonas et al. , 1968; Hsieh et aI. , 1993a; Hsieh et aI. , 1993b; Kahert et aI.
2000; Unanue, 1984; Unanue and Askonas, 1968) and CD8+ T cells (Hamilton-Easton
and Eichelberger, 1995; Usherwood et aI. , 1999). Moreover, it is also well established
that in vitro M~s can tae up and present pariculate and cell-associated antigens on
MHC class I and class II molecules (Kovacsovics-Banowski et aI. , 1993; Kovacsovics-
Banowski and Rock, 1994; Nair et aI. , 1995). Similarly, M~s have been isolated from
animals injected with viruses (Hamlton-Easton and Eichelberger, 1995; Usherwood et
aI. , 1999) or soluble antigen (Grant and Rock, 1992) and shown to present antigen to T
cells ex vivo. It is also well established that M~s acquire antigens from pathogens in vivo
and present them to T cells (Neild and Roy, 2003; Ziegler, 1984). Ths is basis for host
defense against many intracellular pathogens and type IV hypersensitivity responses
(Janeway et aI., 1999). Therefore, M~s clearly acquire antigens in vivo and generate
peptide MHC complexes. In addition, M~s in peripheral tissues that have acquired
foreign material migrate to regional lymph nodes (Kotan et aI. , 1979; Shi and Rock
2002). M~s that reside in the lymph nodes and spleen also perform a filtering fuction
and capture antigen present in blood or lymph (Maino and Joris, 2004). In all of these
situations M~s are stimulating previously activated (effector) T cells or hybridomas
(Janeway et aI. , 1999).
Naive T lymphocytes have more strngent requirements for activation than
effector T cells and hybridomas. The issue of what APC intially stimulates these cells to
initiate immune responses is an importt one. It is well established that DC can
stimulate primar immune responses. It is often argued that DCs are the only APC that
initiate primar immune responses and that M~s play no role in this process (Banchereau
and Steinman, 1998; Inaba and Steinman, 1986; Mellman and Steinman, 2001; Mellman
et aI. , 1998; Norbur et aI. , 2002; Steinman et aI. , 1983; Steinman and Witmer, 1978).
However, the published evidence supporting ths view is relatively limited. Much ofthe
evidence comes from in vitro experiments. However, it is unclear whether these in vitro
experiments accurately model what occurs in vivo.
In sumar, DCs can stimulate primar T cell responses and may be paricularly
potent in doing so. However, on close examination the evidence that they are the only
cells that can prime responses and that M~s lack this capability is relatively scant. It is
possible that DCs are the principal APCs for presenting some antigens (e.g. listeria and
malaria). Whether M~s are also sufficient to prime naive CD4+ T cell responses remains
to be determined.
The ability of both M~s and DCs to acquire and present antigens, express
costimulatory molecules and migrate to the lymph nodes led us to hypothesize that both
M~s and DCs would directly activate naive CD8 + T cells and that this priming would
lead to functional effector cells as well as functional memory T cells.
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Chapter II: Materials and Methods
Animals
C57BL/6 , B6/SJL F1 , Rag - BALB/c f32-microglobtllin deficient (B6. 129P2-
B2mtmIUnC ), mice deficient in Fas (B6.MRL.TNFrsf6 Ipr) Perf orin knockouts (C57BL/6-
PfptmlSdz) and mice congenic for Ly 5. lICD45.1 (B6.SJL-Ptprca Pep3 l Boy) and Thy 1.1
ICD90. (C57BL/6-Igh thy 1 a Gpi 1 a) were initially obtained from The Jackson
Laboratories (Bar Harbor, Maine) and lor bred in specific pathogen-free conditions at
UMASS Medical School. T cell receptor transgenic (TCR) mice OT-I (specific for the
ovalbumin peptide SIINFEKL in the context ofK ) were obtained from Steve Jameson
(Univ. ofMin). D011.10 transgenic mice transgenic mice specific for the 323-339
peptide of ovalbumin in the contact of I - A d were the kind gift of Dr. Dale Greiner
(UMASS Medical School). Breeding pairs of the P- 14 mice specific for KA VYNF A TC
peptide from LCMV gp33 in the context of D were the kind gift of Dr. Ray Welsh
(UMASS Medical School). C57BL/6 mice transgenic for green fluorescent protein were
the gift of Dr. Rachel Gerstein (UMSS Medical School). All T cell receptor trangenic
mice were bred as heterozygotes and housed in the UMASS pathogen free anmal
facility. The transgenic colonies were maintained by breeding transgenic mice to wild
type or congenic C57BL/6 mice. LCMV and OT-I mice were typed using Va2 Vf35.
antibodies for OT-Is and Va2 Vf3 8. 1 antibodies for P- 14 mice and FACS analysis.
D011.10 mice were typed by staining with the clonotypic antibody anti-KJ1-26 and
analyzed by F ACS.
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Antibodies And Reagents
All antibodies for F ACS analysis uness noted were purchased from Pharingenl
BD (San Diego , CA). The clonotypic antibody anti-KJ1-26 was purchased from Caltag
(Burlingame, CA). Anti-CD45. 1 was purchased from ebioscience (San Diego , CA).
Intracellular cytokine reagents including antibodies were also purchased from
Pharingenl BD (San Diego, CA). Peptides with the following sequences were
generated by Steve Reed at Corixa (Seattle, W A): ISQA VHAAEINEAGR
(D011.1O), SIINFEKL (OT-I) and KA VYNAFATC (gp33)
Generation of Fl chimeras
B6/SJL F 1 mice were lethally irradiated using 1200 rad. Bone marow was
prepared from the femurs and tibias ofC57BL/6 mice or BIO. /sgMcdJ donor mice
and depleted ofT cells using a monoclonal antibody against Thy 1 , M5/149 (ATCC) and
complement (PEL-Freeze). The irradiated mice were reconstituted with 2.5x10 T cell
depleted-bone marrow cells given intravenously. The mice were than housed for 3-
months in a SPF environment to allow for the tuover and reconstitution of the antigen
presenting cells in the peripheral tissues. The reconstitution of the chimeras was tested
by adoptively transferrng transgenic T cells (either OT-I or P- 14) and challenging the
anmals with OVA coated beads (Kovacsovics-Banowski et aI. , 1993) or a 13mer from
gp33 , KA VYNF A TCGIF A (Ciupitu et aI. , 1998), both of which have previously been
shown to prime naive T cells in a D restricted maner. In all cases, these antigens failed
to stimulate the TCR-tg T cells in F1 chimeric anmals whose bone marow lacked H-
indicating that the host APCs had been completely eliminated.
Production of bone marrow-derived macrophages and dendritic cells
Femurs and tibias were collected from C57BL/6 mice and flushed using RPMI-
1640 containng 10% FCS , 2 mM glutane, IX antibiotic-antimycotitc, 100 
HEPES , 1 00 M nonessential amino acids and 5 x 10 2-mercaptoethanol , complete
media (Life Technologies, Carlsbad, Californa). The red blood cells were lysed using
ACK Red Cell lysis buffer and the cells were washed. The cells were resuspended in
complete RPMI and plated in non-tissue cultue treated Petri dishes for an overnght
incubation at 37 oC in 5% C02 incubator. The next day, nonadherent cells were collected
counted and adjusted to 0.5 x10 cells/ml in complete media. BM cells (7.5 X 10 cells)
were plated in 100 mm tissue cultue suspension dishes (Costa) in the presence of 10
ng/ml GM-CSF and 5 ng/ml IL-4. BM cells were plated in the same maner except DAP
supernatants were added as a source ofM-CSF at a final concentration of 10%. DAP
supernatat were generated by culturng confuent DAP cells for 5-7 days. Supernatants
were collected and fiter sterilized and stored at C. The BM cells were incubated at
37 oC in 5% CO incubator. After 7 days, the cells were removed from the dishes using
rubber policemen. The APCs were incubated with the indicated peptides for 2 hours in
complete RPMI and then washed 3 times with Hans Balanced Salt Solution (HBSS)
without Mg and Ca+2 (Gibco).
Analysis ofpeptide-MHC complexes
M~s and DCs, incubated with 10 M SIINFEKL in complete RPMI at 37 0 C in a
5% C02 incubator for 4 hours, were washed 3 times in HBSS and replated in complete
RPMI at 0.5 x10 cells/ml. Cells were scraped up at varous time points and incubated
with biotinylated 25D 1. 16 antibody for 45 minutes. 25D 1. 16 recognizes SIINFEKL in
the context ofK (Porgador et aI. , 1997). Samples were then washed 2 times with HBSS
+ 5% FCS and incubated with Strep-avidin-APC (BD/Pharmingen) for an additional 45
minutes. Samples were washed twice with HBSS+5% FCS. The cells were then fixed
using 1 % paraformaldehyde and stored at 4 C until analysis. Samples were analyzed
using a F ACS Calibur and FlowJo analysis software.
Adoptive Transfer Experiments
Adoptive transfer experiments were done as previously described by Jenkins
(Ingull et aI., 1997). Briefly, T cells were isolated from lymph nodes of transgenic mice
and purified by nylon wool or complement depletion (Pel-Freeze) depletion using an
anti-class II (M5/114) and an anti-HSA antibody, J11D, ATCC). OT-I/Rag OT-I/GFP
or P-14/Rag f- animals were also used as a source of T cells for some experiments. The
transgenic T cells are then labeled with M CFSE (Molecular Probes, Eugene, OR) in
HBSS without seru for 20 minutes at 37 oC. The cells were than washed once with
HBSS without Mg and Ca (Life Technologies) supplemented with 5% FCS followed
by seru free HBSS. One day prior to immunzation, 2.5x10 - 4.0 x10 transgenic T
cells were adoptively transferred into host anmals, which resulted in Tg T cells
consisting of about 1% of CD8+ T. On day 0, DCs or M~s pulsed with the appropriate
peptide in complete media for -3 hours in 5% C02 at 37 C. After washing 3 times
without seru the 0.5x10 or 1x10 APCs were injected either subcutaeously or
intravenously, depending on the experiment. Non peptide-pulsed APCs were used as a
negative control.
FACS Staining and Analysis
Drainig lymph nodes and/or spleens were harested at various times after APC
transfer and made into single cell suspensions. The cells were incubated in 2.4G2 to
block Fc receptors for 10 minutes. The cells were then stained with PerCP conjugated
anti-CD8 (Pharingen) and either allophycocyanin conjugated anti-Ly 5. (Pharingen)
or Cy 5 conjugated anti-Thy 1.1 (e Bioscience San Diego, CA)) and their CFSE content
was examined using flow cytometr.
Antigen Presenting Cell Migration Experiments
Cells were removed from the Petri dishes and labeled with M Cell Tracker
orange (excitation at 548 nm and emission at 576 nm) or Cell Tracker green (Molecular
Probes) dye (excitation at 492 nm and emission at 517 nm) HBSS without seru at a
concentration of .:5x106 cells/ml for 45 minutes at 37 C. The cells were then washed
once with 5% FCS in HBSS and 2 more times with HBSS without seru. Draining
lymph nodes were harested and incubated with 2.4 g/m1 collagenase and 1 g/ml 
DNase (Boehrnger Maneim) for 90 minutes at 37 0 C. The lymph nodes were then
drawn through a 23 G needle to make a single cell suspension. The cells were then
washed twce and allowed to recover for 2 hours at 4 C in complete media. The cells
were stained with antibodies against Ly 5. 1 (Pharingen) and analyzed by FACS. In
some experiments the cells were tracked by CFSE labeling before injection or GFP
content.
Fluorescent Aficroscopy
The draining lymph nodes were removed at various times after DCs and snap
frozen in "Tissue-Tek" OCT compound (Miles Inc.) on a dry ice ethanol bath. Sections
were than made on a microtome at 4 I-m or 25 I-m thicknesses. The sections were
mounted on glass slides and fixed in 4% paraformaldehyde for 20 minutes. 4 I-m
sections were examined using a Olympus fluorescent scope with a CAD camera mount.
Analysis was performed using Adobe Photoshop. The 251-m sections were analyzed
using the UMASS microscopy core facility and Z-axis deconvolution softare.
Intracellular Cytokine Staining
Adoptive transfer experiments were done as described above. Thee or four days
after transfer of the APCs, lymph nodes and/or spleens were removed, minced and made
into a single cell suspension. Cells were stimulated in vitro with either media alone or
with the cognate peptide (SIINFEKL g/m1 or KA VYNAF A TC 5 g/m1) in the
presence of Brefeldin A for 5 hours. The samples were then washed and stained for
CD8+ and Ly5. 10r Thy 1.1 depending on the experiment for 30 minutes. The samples
were then fixed with CytoPermCytoFix (Pharngen, San Diego, CA) for 20 minutes in
the cold. The cells were then permeabilzed with PermWash (Pharingen, San Diego
CA). PE-Anti-IFN-y, clone XMG (Pharingen, San Diego, CA) was added in the
presence ofPermWash for 45 minutes. The samples were washed twce assayed by flow
cytometry .
In Vivo Cytolysis
The in vivo cytolysis assays were done as described previously by Ahmed et at.
(Barber et aI. , 2003). Briefly, at varous times points after priming, peptide pulsed 5
!-g/ml and unpulsed Ly 5. 1 CFSE labeled splenocytes targets were injected intravenously.
Twenty to twenty-four hours later, lymph nodes or spleens were removed and stained
with APC- anti-Ly 5. 1. Samples were analyzed by flow cytometry. Percent killing was
calculated according to the following formula: 100-f((%peptide pulsed in primed)/%
unpulsed in primed)/% peptide pulsed in unprimed/% unpulsed in unpried)) X 100 
Plaque Assays
At various times after immunzation with peptide coated APCs, mice were
challenged with 4-5x10 PFU LCMV interperitoneally. Thee days after infection
spleens were removed and homogenized using a tissue homogenizer. The homogenates
were spun to remove debris and frozen at -80 oc. lO-fold serial dilutions of the
homogenates were made and added to veros cell monolayers plated at 60-70 % with an
agar overlay. 24 hours after infection, neutral red was added in more overlay mixtue.
24-48 hours later, plaques were visualized using a light box and counted. Viral titers
were calculated according to the following formula: PFU/ml = plaques counted x dilution
x volume added).
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Chapter III: Macrophages Prime Naive CDS+ T Cells In Wild
Type Mice
Results
Dendritic Cells And Macrophages Can Both Stimulate Primary T Cell Responses In
Vivo
In order to study the ability of different types of antigen presenting cells to prime
naIve T cells, we grew M~s and DCs from mouse bone marow. We first analyzed these
cells for their expression ofCD11c, MHC molecules, CD80 , and CD86. Of the bone
marow cells cultued in GM-CSF and IL- , about 70% differentiated into DCs, as
defined by expression of the pan DC marker CD 11 c; although these cells were not
homogeneous, we wil henceforth refer to them as DCs. The DCs used in this thesis are
the myeloid derived Class II+ CD 11 b +, CD 11 C+ DCs. In contrast, the bone marow
cultued in M-CSF , which stimulates the growth ofM~s, totaly lacked the expression of
the CD11c DC marker (Fig. 1). The presence of these phenotypic markers in addition to
the morphology of these cells led to the classification of them as M~s.
Although the M~s are biphasic for MHC class I expression, the majority of them
express similar levels of these molecules as DCs. Similarly, the levels of CD80 and
CD86 on the majority of both cell types are about the same. Although the majority of
DCs (-80%) are of the immatue phenotype as defmed by surace markers, a small
subpopulation of the DCs ( 20%) is more matue as indicated by the higher expression of
class II , CD80 and CD86. The population of M~s was also biphasic for MHC class II
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Figure 1: Characterization Of APC Populations.
Bone marow-derived M~s and DCs were cultued as described in the Material and
Methods section of ths thesis. In all panels M~s are shown in the solid line and DCs
are shown in the dashed line. Panel A shows the levels of MHC I, panel B= MHC II
panel C=CD80 , panel D= CD86, panel E=CD 11 c and panel F is Pe-anti IA d antibody
used as a negative controL This experiment was repeated 4 times.
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with about 40 % expressing moderate levels and 60% expressing low to undetectable
levels of class II molecules (Fig. 1). To test the ability of these APCs to stimulate T cells
we used an adoptive transfer system similar to that described by Jenkns et al. CD8+ T
cells from P- 14 LCMV T cell receptor transgenic mice, specific for the gp33 peptide
(KA VYNF A TC) presented on D (Pircher et aI. , 1993), were labeled with CFSE and
transferred intravenously into C57BL/6 mice. Twenty-four hours later these mice were
injected subcutaeously into the footpad with gp33-pulsed bone marow-derived DCs or
M~s. Unpulsed APCs were used as a negative control. Four days after the injection of
the APC, the draiing lymph node (popliteal) was removed and made into a single cell
suspension. Lymph node cells were stained for CD8 and CD45. 1 or CD90. 1 to identify
the antigen specific T cells and analyzed by flow cytometry. In anmals immunzed with
either M~s or DCs pulsed with peptide, the transgenic T cells proliferated significantly,
as indicated by the progressive dilution of CFSE label with each division (Fig. 2). 
contrast, antigen specific T cells did not proliferate in anals primed with unpulsed DCs
or M~s. Figure 2 also demonstrates that the amount of peptide needed to induce
proliferation of the antigen specific T cells is about lO-fold higher for M~s than it is for
DCs when they are injected subcutaeously. Thus it takes at least g/ml of
KA VYNF A TC to elicit a T cell response when M~s are used as the priming APC where
as only 100 ng/ml is needed for DCs. At the high (non-limiting) doses ofKA VYNFATC
DCs and M~s stimulated equal proliferation and percentage accumulation of termnally
divided T cells (77% for DCs vs. 81 % for M~s)(Fig. 2).
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Figure 2: Titration Of Gp33 Needed To Prime Naive P-14 T Cells
Draining lymph nodes were harested four days after APC transfer, minced, stained and
analyzed by FACS analysis. The X- axis depicts the level ofCFSE content of the
transgenic T cells whereas the Y-axis represents relative cell number. The different
panels represent the increasing concentration of gp33 used to pulse the APCs. The top
row of panels shows the results of DC immunization with the varous peptide
concentrations and the bottom row shows the results for M~ immunzations in the same
experiment. This experiment was repeated at least five times with a total n=6 animals for
the lower peptide concentrations and n:: 25 for the higher peptide concentrations.
Figure 2: Macrophages Prime Naive P-14 T Cells
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To make sure this stimulation of transgenic T cells was not peculiar to a particular
TCR transgenic system, the experiment was repeated using different TCR transgenic T
cells. We adoptively transferred OT-I T cells specific for the SIINFEKL peptide (OV A-
p) present in the context of K (Hogquist et aI. , 1994) into C57BL/6 mice (Fig 3). The
different color traces represent two different animals. We frequently see some level 
animal-to-animal varation in these types of experiments. The M~s were also able to
stimulate naive OT-I T cells. A similar 10-fold difference in potency was observed when
M~s and DCs coated with SIINFEKL were used to stimulate ovalbumn-specific OT-
transgenic T cells (Fig 3).
The prevailing view has been that DCs are the principal cells that stimulate naIve
T cells (Banchereau and Steinman, 1998; Belz et aI. , 2002c; Steinman et aI., 1983). It
was therefore surrising to find that M~s stimulate such strong primar T cell responses.
Consequently, we evaluated whether contaminating DCs might actully account for the
abilty of cultued M~s to prime T cell responses. As described above, the cultued M~s
contained ':1% (essentially undetectable) cells expressing the CD11c DC marker (Fig. 1),
which is expected because DCs are not stimulated by the M-CSF used to grow M~s. 
tested whether 1 % or less of containating DCs would be suffcient to prime T cells. 
shown in Fig. 4, the minimum number of DCs needed to prime T cell responses in our
system was - ':50 000, which is far above what could be contaminating our M~ cultues.
Figure 3: Macrophages Prime Naive OT -I T Cells
CD90. 1 congenic lymph node cells OT- l T cells were transferred IV into C57BL/6 mice.
The next day, mice were immunized SQ with APCs pulsed with varous concentrations of
OV A-p peptide. Three days later, the draining lymph node was removed and stained
with antibodies against CD8 and CD90. 1. The samples were gated on live, CD8+ and
CD90. 1 + cells and analyzed for CFSE content. The red and blue lines represent
independent mice from the same experiment. This experiment was repeated 3 times with
a total n=8 mice/peptide concentration.
Figure 3: OT-I Dose Response to SIINFEKL Peptide
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Figure 4: At Least 50,OOO"Dendritic Cells Are Needed To Elicit T Cell
Responses.
CD45. + congenic CFSE labeled P- 14 T cells were adoptively transferred into C57BL/6
mice. The next day, mice were immunized IV with varous numbers of DCs pulsed with
10 I-g/ml of the gp33 peptide. Three days later, the draining lymph node was removed
and stained with antibodies against CD8 and CD45. 1. The samples were gated on live
CD8+ and CD45. + cells and analyzed for CFSE content. The different color lines
represent independent mice from the same experiment. This experiment was repeated 3
times with a total n=9 mice/cell number.
Figure 4: Number of Dendritic Cells Needed to Induce T Cell Proliferation
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To fuer assess this point, we also tested M~ and DC lines, which are cloned and lack
any contaminating cell type (Kovacsovics-Banowski and Rock, 1994; Shen et aI. , 1997).
We found that both the C2.3 and A3. 1 M~ cell lines stimulated primar OT-I T cell
responses, and did so equivalently to the DC 2.4 cloned DC line (Fig. 5). In these panels
the red trace represents the degree of T cell proliferation observed when unpulsed cells
lines are used as an APC. We believe ths moderate level of background is due to the
presentation of endogenous peptides or seru proteins by the cloned cells. These
experiments were repeated using P-14 T cells and the C2.3 M~ cell line and DC2.4 DC
line (Fig. 6) and again demonstrated M~ and DC priming ofT cells. In this figure the
different lines represent the result of independent mice. As noted above, varability
between anmals is frequently observed. Overall, we conclude that peptide-pulsed M~s
can stimulate primar T cell responses and that these responses are not being stimulated
by contanating DCs.
Comparison Of Dendritic Cell And Macrophage Priming Of T Cell Responses.
As shown in the previous section, the degree of T cell proliferation as well as the
amount of T cells present in the terminal division peak is dependent on the dose of
peptide used to coat the APCs (Figure 2) as well as the cell type used for presentation.
The overall level of proliferation and accumulation of terminally divided antigen specific
T cells in the P-14 system was similar when anmals were stimulated with either M~s or
DCs at high doses of peptide, but the kinetics of the responses were different.
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Figure 5: Cell Lines Can Stimulate Naive OT -I T Cells.
OT-I lymph node T cells were adoptively transferred into C57BL/6 mice. The next day,
mice were immunzed SQ with the two M~ cell lines and one DC line pulsed with
various concentrations of SIINFEKL peptide. Four days later, the draining lymph node
was removed and stained with an antibody against CD8. The samples were gated on live
and CD8+ cells and analyzed for CFSE content. Panel A shows the proliferation seen
when M~ cell lines are used as the stimulation APC. Panel B shows the results obtained
when a DC cell line is used as the stimulating APe. The red line represents the
background T cell proliferation seen with unpulsed cell lines used as a negative control.
The blue line represents T cell proliferation in the mouse that received OV A-p pulsed
APCs. This experiment was repeated 3 times with 2 mice being immunized with each
concentration of peptide pulsed cell line for a total n=6 mice/group.
Figure 5A: Stimulation of OT -I T Cells by Macrophage Cell lies
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Figure 5B: Stimulation of OT -I T Cells by Dendritic Cell Line
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Figure 6: Stable Cell Lines Can Also Stimulate Naive P-14 T Cells.
CD90. 1 congenic P- 14 T cells isolated from lymph nodes were adoptively transferred
into C57BL/6 mice. The next day, mice were immunzed SQ with cell lines pulsed with
various concentrations of gp33 peptide. Three days later, the drainig lymph node was
removed and stained with antibodies against CD8 and CD90. 1. The samples were gated
on live, CD8+ and CD90. 1 + cells and analyzed for CFSE content. The black and blue
lines represent two independent mice from the same experiment. This experiment was
repeated 3 times with a total n=6 mice/peptide-pulsed cell line.
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Figure 6: Stable Macrophage and Dendritic Cell Lines Prime Naive P-14 T Cells
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Transgenic T cells in the M~ primed animals consistently reached their peak frequency
3 days after priming, whereas the peak was on day 4 in animals primed with DCs (Fig 7
A).
The ability of the M~s and DCs to stimulate equal T cell expansion in the P-
system was in contrast to what was seen when OT-I T cells are used as the responding T
cells. When OT-I T cells were adoptively transferred and stimulated with peptide
pulsed M~s given subcutaeously, the peak accumulation was less than seen when the T
cells were stimulated with DCs. This can be seen in Figure 7B. When transgenic T cells
were primed with DCs, up to 38 % of the CD8 T cell pool were OV A-p specific. In
contrast, transgenic T cells stimulated by peptide-pulsed M~s only expanded to 10 % of
the CD8+ T cell pool. The reason for the difference in the amount of expansion of OT-
versus P- 14 T cells stimulated with M~s is not known. Nevertheless, given that the
initial precursor frequency of OT -I T cells was only about 1 % the expansion seen with
both APCs is stil impressive. The experiment was also done using CD90. 1 congenically
marked OT-I T cells.
It is possible that the 10- fold difference in the concentration of peptide needed to
elicit T cell responses by DCs versus M~s was due to differences in their respective
expression of co stimulatory molecules, although the majority of these cells express
similar levels of CD80 and CD86 after in vitro cultue (Fig. 1 ).
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Figure 7: Overall Accumulation Of Antigen Specific T Cells.
A. 2.5x10 CD45. + P- 14 T cells labeled with CFSE were transferred into wild type
hosts. One day later the anmals were immunzed SC with either gp 33-pulsed
M~s (100 g/ml) or gp33-pulsed DCs (10 g/ml). The drainig lymph nodes
were removed 2, 5 and 7 days after APC transfer. Single cell suspensions
were made and the cells were stained with CD45. 1 and CD8 and analyzed by
FACS. The red trace represents an anmal that received gp33-pulsed DCs and the
blue trace represents an anal that received gp33-pulsed M~s. This experiment
was repeated 3 times with a total number of a total n= 6 mice/time point.
B. 2.5x 10 GFP+ OT - I transgenic T cells were transferred into C57BL/6 hosts. One
day later the anals were imunzed SC with M~s or DCs pulsed with 1 mg/ml
of OV A-p. Draining lymph nodes were removed 2, 3, 4, 5 and 6 days after APC
transfer. The lymph nodes were made into single cell suspensions and stained
with anti-CD8 antibodies and analyzed by F ACS. The data are depicted as the
percentage ofCD8+ T cells expressing GFP. The red (M~) and green (DC) traces
represent animals that received unpulsed APCs. The fuchsia (DC) and blue (M~)
traces represents anmals immunzed with APCs pulsed with OV A-p. This
experiment was repeated 3 times with a total number of a total n= 6 mice/time
point.
Figure 7A. Overall Accumulation of Antigen Specifc P-14 T Cells
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Other possible differences include the level of level of MHC I-peptide complexes and the
ability of the APCs to home out of the subcutaneous space in to the lymph node. 
investigate some of the other possible basis for this difference in potency we perfonned
several additional experiments. We first examined whether the cells were presenting
similar numbers of peptide-MHC complexes. For this analysis we used the ovalbumin
peptide SIINFEKL because this system also shows a similar potency difference between
M~s and DCs and the number of Kb SIINFEKL complexes can be quantified with the
mAb 25D1.16. M~s and DCs were incubated with SIINFEKL peptide , stained with
25Dl and analyzed by flow cytometry. Unpulsed APCs were used as negative controls.
Similar numbers of K SIINFEKL complexes formed on the peptide pulsed M~s and
DCs (Fig.8). Interestingly, however, we observed a vastly different half-life of the
complexes on the two cell types. Even after 96 hours, the vast majority of DCs stil
expressed detectable levels of K SIINFEKL and, remarkably, on a subpopulation of DCs
the levels of these complexes was essentially unchanged after 4 days. The cells that stil
have high-level complexes at 96 hours are the CD80/CD86, class II high population of
mature DCs (data not shown). In shar contrast, M~s have lost most if not all of their
SIINFEKL complexes by 48 hours.
Whle the differences in the expression of co stimulatory molecules and half-life
ofpeptide-MHC complexes might contribute to the difference in potency between M~s
and DCs, we also examined whether DCs and M~s migrate with
Figure 8: SIINFEKL- Complexes Are More Stable On the Surface of
Dendritic Cells than On Macrophages.
Bone marow-derived M~s and DCs were cultued as previously described. The APCs
were than pulsed with 10 !!g/ml of OV A-p for 4 hours. The cells were than washed
extensively and replated. Cells were harested at 0 , 24, 48 , 72 and 96 hours after pulsing
and stained with biotin-labeled 25D1. After incubation with strepavidin-APC the cells
were washed and analyzed by FACS. Panel A shows the half-life ofSIINFEKL-
complexes on DCs and Panel B shows the same data for M~s. The black line represents
the background levels of 25D 1 staning on unpulsed APCs. Ths experient was
repeated with 4 different DC and M~ preparations.
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Figure 8: Half-life ofSIINFEKL- Complexes on the Surface of the APCs
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different effciencies. In initial studies we injected mice subcutaneously with dye-labeled
APCs and then examined sections of the draining lymph nodes. After 24 hours, we
observed by fluorescent microscopy that there were more labeled DCs than labeled M~s
in the draining lymph nodes (data not shown). To determine whether the lesser migration
of M~s contrbute to their reduced potency relative to DCs in priming T cells, we
performed two additional experiments. The number of APCs that migrate to the lymph
node is proportional to the number injected. Therefore, in the first experiment, we
injected mice with four times the number of peptide-pulsed M~s, while keeping the
number ofDCs constant. Under these conditions, M~ and DCs stimulated an equal
expansion of the antigen specific T cells to the same concentration of peptide. Increasing
the number ofM~s injected had a greater effect than increasing the peptide concentration
lO-fold (Figure 9). In a second experiment, M~s and DCs were pulsed with 10 J.M of
gp33 and injected intravenously one day after the transfer ofCFSE labeled P-
transgenic T cells into C57BL/6 mice. We reasoned that the intravenous injection of
M~s and DCs might allow the two APCs to home in more similar numbers to the spleen
and lymph nodes.
Figure 9: Injecting More Macrophages Result is Better T Cell Priming.
5x10 CD90.1 + P- 14 T cells labeled with CFSE were transferred into wild type hosts.
One day later the anmals were immunzed with 0.5 x106 (tuquoise), 1 x10 (dark blue)
or 2 x10 (bright green) M~s pulsed with 10 g/ml of gp33. Additional anmals were
immunzed with 0.5 x10 M~s pulsed with 100 g/ml of gp33 (fuchsia). 0.5 x10
unpulsed DCs (black) or DCs pulsed with 1 0 g/ml of gp33 (red) were used as a positive
and a negative control, respectively. Lymph nodes were harested on day 3 from the
anmals immunzed with M~s and on day 4 from the animals immunized with DCs
because this is the day of peak T cell proliferation (see Fig. 7 A). The data are
represented as percentage of CD8+ T cells that are transgenic T cells. Ths experiment
was repeated 3 times for a total of 6 mice/group.
Figure 9: Injecting More Mw Results in More T cell Accumulation
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To analyze the proliferation ofthe P- 14 transgenic T cells after intravenous injection of
the APCs, inguinal lymph nodes and spleens were removed 3 , 4 and 6 days post injection.
The results of a representative experiment are shown in Figure 10. By day 2, one can
detect the presence of transgenic T cells that have proliferated in the spleens of anmals
pried with both M~s and DCs. Proliferating transgenic T cells continued to be present
in the spleens of these animals from day 3 through day 6. The lymph nodes of these
anmals present a slightly different pictue. Three days after immunzation, only mice
injected intravenously with peptide-pulsed M~s have proliferating T cells in the draining
node. From day 4 though day 6, essentially equal numbers of proliferating transgenic T
cells can be detected in the lymph nodes of anmals immunzed with DCs and M~s.
Therefore, immunzation of anmals with 10!-g/ml of gp33-pulsed APCs via the
intravenous route led to identical levels of P- 14 transgenic T cell proliferation and
expansion (Fig. 10). In case we were missing the difference in the abilty of the different
APCs to prime via the IV route, we repeated the experiments using APCs pulsed with a
series of3-fold dilutions of gp33. This experient was done as previously described.
Three days after APC transfer, the mice were sacrificed and spleens were removed. The
results of a representative experiment can be seen in Fig. lOB. The result of this
experiment was identical to those of the experiment described above. This set 
experiments demonstrates that when M~s are given intravenously they are able to prime
naIve P-14 transgenic T cells as effectively as DCs.
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Figure 10: Macrophages Delivered IV Prime As Well as Dendritic
Cells.
A. 2.5x106 CFSE labeled CD90.1 + P- 14 T cells were adoptively transferred into
C57BL/6 mice. The next day, the animals were immunzed with M~s or DCs
pulsed with 1 g/ml of gp33 via the intravenously route. After varous days
spleens and inguinal lymph nodes and spleens were removed, stained for CD8 and
CD90. 1 and analyzed by F ACS. Anmals that received M~s are shown by red
lines and anials that received DCs are shown by black lines. This experiment
was repeated 4 times with a tota n=10 mice/group.
B. 2.5x10 CFSE labeled CD90. + P-14 T cells were adoptively transferred into
C57BL/6 mice. The next day, the animals were imunzed with M~s or DCs
pulsed with 0. , 0.3, 1.0 and 1 g/m1 of gp33 via the intravenously route. Three
days later, the spleens were removed, stained for CD8 and CD90. 1 and analyzed
by F ACS. The different color lines represent 2 or 3 anmals in the same treatment
group. This experiment was repeated 2 times with a total n=6 mice/group.
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Figure lOA: M s Prime Naive T Cells As Well As DCs When Injected Intravenously
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Figure lOB: Macrophages Prime Naive T Cells As Well As DCs When
Injected Intravenously
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We had reasoned that intravenous injection of the APC would result in similar
numbers of migrating cells, so we decided to quatitate the number of cells migrating
into the secondar lymphoid organs after SC and IV imunization. We found that just
about equal numbers ofDCs and M~s were found in the spleen after IV injection (Fig
lIB). Quite a different pictue was observed for the SC injections. After SC injection
we observed - fold more DC than M~ in the drainng lymph nodes in this experiment
(range for other experiments 5- 1 O-fold). The results from a representative experient
can be seen in Fig. 11A. We were unable to reliably detect the migration of either APC
to the inguinal lymph nodes when delivered intravenously.
Peptide-Pulsed T Cells Are Unable To Stimulate Responses
To determine if the capability ofM~s to prime naive transgenic T cells is
relatively unque or if any MHC class I positive cell can prime naive transgenic T cells
we investigated whether T cells could also fuction as APCs in this model. T cells were
chosen because they express class I molecules at high levels, can present peptide and
migrate into the T cell areas of the secondar lymphoid organs. As a source of T cell
APCs in these experiments, CD8+ T cells were isolated from the lymph nodes of OT-
mice bred on to a Rag-deficient background. These mice were used to provide a
homogeneous pure population of T cells of irrelevant specificity that lacked any possible
B cell contamination. The OT-I T cells were pulsed with gp33 and injected SC into mice
containng CFSE-Iabeled P- 14 T cells. The pure population ofCD8+ T cells was
completely unable to stimulate the naive P- 14 T cells to proliferate or expand (Fig. 12).
In contrast, in the same experiment M~s and DCs stimulated P- 14 T
Figure 11: Dendritic Cells Migrate More Efficiently Out Of The
Subcutaneous Space Than Macrophages.
A. 10x10 CFSE labeled M~s or DCs were injected SC. Twenty-four hours later,
popliteal lymph nodes were removed and digested with collagenase and DNAse for
90 minutes. The nodes were made into single cell suspensions by pulling through a
25 G needle. Lymph nodes from an anmal that did not receive any APC were used
as negative controls. Samples were then analyzed by F ACS analysis. The mean for
the M~s samples= 102.2 and the mean for the DC samples =798.7. These
experiment is representative of5 experiments with a total n=14 for M~s and an n=ll
for DCs.
B. DCs And Mws Migrate to the Spleen With Equal Effciency When
Injected IV.
B. 10x10 CFSE labeled M~s or DCs were injected intravenously. Twenty-four hours
later, spleens and inguinal lymph nodes were removed and digested with collagenase
and DNAse for 90 minutes. The organs were made into single cell suspensions by
pulling though a 25 G needle. A spleen from an anmal that did not receive any
APC was used as negative controls. Samples were then analyzed by F ACS analysis.
The mean for the M~ samples= 2474.5 and the mean for the DC samples =2298.
These experiment is representative of 5 experiments with a total n= 15 for M ~s and
an n=9 for DCs.
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Figure llA: Dendritic Cells Migrate To LNs After SC Injection More Efficiently
Than Macrophages
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Figure llB: Dendritic Cells And Macrophages Migrate With Equal Efficiency When
Injected IV
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Figure 12: Subcutaneously Injected Peptide-pulsed T Cells Are Unable
To Prime Naive P-14 CDS+ T Cells.
5x106 CD45. 1 congenic P- 14 were CFSE labeled and adoptively transferred into
C57BL/6 mice. One day later, the mice were immunzed with Rag
I- OT-I T cells, M~s
or DCs pulsed with 0. , 10 or 100 f.g/ml of gp33. Three days later, drainng lymph nodes
were removed and stained with CD8 and CD45. 1 and analyzed by F ACS. The data are
shown as CFSE content of the CD8+ CD45. + T cells. The different color lines represent
different animals in the same group. This experiment was repeated 3 times with a tota
n=8 mice/group.
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Figure 12: T Cells injected SC Are Unable to Prime Naive P-14 CD8 + T Cells
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cells demonstrating that the CFSE labeled P- 14 T cells were capable of proliferating (Fig.
12). As a control for migration, T cells from GFP transgenic mice were injected
subcutaneously into the footpad of mice. By cryosections and fluorescent microscopy,
we have found that the T cells do migrate to the draining lymph node (data not shown).
To fuer verify that the failure of gp33 pulsed Rag-/OT-I T cells to induce proliferation
of P- 14 TCR transgenic T cells was not due to their inabilty to home to the drainig
lymph node in suffcient numbers, we injected the OT-I T cell APCs intravenously.
Under these conditions the T cell "APCs" migrate effciently to the secondar lymphoid
organs, however as shown in Fig. 13, they are again very poor APCs. Although the
peptide-pulsed T cells were able to induce a small amount of proliferation of the P- 14 T
cells, no more than 3 divisions were observed as seen in Fig. 13. There were also no P-
14 T cells accumulating in the later division peaks. Evidence wil be presented in the
next chapter that this very limited response is not being directly stimulated by the OT-I T
cells, but by cross-presentation. Therefore, not all MHC class I expressing cells can
stimulate naIve T cells, even when the "APCs" can home to the T cell areas in the
lymphoid organs.
Macrophages And Dendritic Cells Stimulate The Generation Of Effector T
Cells.
Effective immune responses require that T cells not only proliferate but also
express effector fuctions. Under some conditions, T cells can be stimulated to undergo
Figure 13: Peptide-Pulsed T Cells Injected Intravenously Are Very Poor
APCs.
5x106 CD45. 1 con genic P- 14 were CFSE labeled and adoptively transferred into
C57BL/6 mice. One day later, the mice were immunzed with OT-IlRg cells, M~s
or DCs pulsed with 0.0 or 10!-g/ml of gp33. Three days later, spleens and inguinal lymph
nodes were removed and stained with CD8 and CD45. 1 and analyzed by FACS. The
different color lines represent different anmals in the same group. This experiment is
representative of 3 experiments with a total n=6 mice/group.
Figure 13:Peptide-Pulsed T Cells Injected Intravenously Are Very Poor APCs.
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many rounds of cell division but become anergic and fail to express effector fuctions
(Adler et aI. , 2000). In order to determne if both DCs and M~s stimulate naIve P- 14 T
cells to become effector cells, we first analyzed whether the proliferating T cells were
producing the effector cytokine IFN-y. Adoptively transferred P-14 T cells were
stimulated in vivo with peptide-pulsed M~s or DCs administered SC for the OT-
experiment and IV for the P-14 experiment as described above. Three or four days after
the APC transfer, the draining lymph nodes were removed made into single cell
suspensions and cultued in vitro with or without gp33 or OV A-p peptide in the presence
of Brefeldin A for 5 hours prior to staining for intracellular IFN-y. Shown in Table 1 and
Fig. , both M~s and DCs stimulated naIve P-14 T and OT-I cells to produce IFN-
Although fewer T cells are primed by the SC administered M~s (Fig. 14), the primed T
cells are makg the effector cytokine and are therefore fuctional. When the APC were
given IV (Table 1), the percentage ofT cells makng IFN-y was similar for both APCs.
Consistent with previous reports, only T cells that have under gone multiple rounds of
division are making significant amounts of IFN-
We next analyzed the abilty of both M~s and DCs to induce cytolytic function
using in vivo cytolysis assays as described (Barber et aI. , 2003). In these experiments
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unlabeled P- 14 T cells were adoptively transferred into C57BL/6 mice. The next day,
gp33-pulsed M~s or DCs were given IV. Various days after APC transfer, CD45.
con genic gp33-pulsed and unpulsed splenocytes labeled with two different CFSE
concentrations were given IV.
Table 1: P-14 T Cells Produce IFN-y After Priming In Vivo In C57BL/6
Mice.
CSFE labeled CD45. 1 + P- 14 T cells were adoptively transferred into C57BL/6 mice.
One day later, the mice were immunzed IV with M~s or DCs pulsed with 10 g/ml.
Three days after imunzation, splenocytes were incubated with 5 g/ml of gp33 or
media as a control for 5 hours in the presence of Brefeldin A. Samples were then stained
for CD45. , CD8 and intracellular IFN-y. The data were gated on CD8 , CD45. 1 + cells
and expressed as % transgenic T cells producing the cytokie. This experiment 
representative of 3 experiments with a total n=6 mice/group.
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Table 1: P-14 T Cells Produce IFN-y After Priming in Vivo in C57/BL6 Mice
Stimulating APC % Transgenic T cells secreting IFN-y
No Antigen 1.54
DC 10 Jtg/ml peptide mouse 1 37.
DC 10 Jtg/ml peptide mouse 2 31.5
10 Jtg/ml peptide mouse 1 30.
10 Jtg/ml peptide mouse 2 27.
Figure 14: IFN-y Secretion Of OT-I T Cells Primed In Vivo.
CSFE labeled CD90. 1 +, P- 14 T cells were adoptively transferred into C57BL/6 mice.
One day later, the mice were imunized SC with M~s pulsed with 10 f.g/ml or DCs
pulsed with 1.0 f.g/ml of OV A-p. Four days after immunzation, draining lymph node
cells were incubated with 1.0 f.g/ml OV A-p or media as a control for 5 hours in the
presence of Brefeldin A. Samples were then stained for CD90. , CD8 and intracellular
IFN-y. The data were gated on CD8 , CD90. + cells and plotted as transgenic T cells
producing IFN-y versus CFSE content. This experient is representative of 3
experiments with a total n=6 mice/group.
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Figure 14: IFN-y Secretion by OT -I T cells on Day 4
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Eighteen hours later, the animals were sacrificed and spleens were removed and analyzed
by FACS. Both DCs and M~s were able to prime CfL effector cells that lysed the
peptide-pulsed targets. Cytolytic activity was seen as early as 2 days after priming and
reaches a maximum by day 4. We observed no cytolytic activity after day 12 in primed
animals (data not shown). On day 5, two animals primed with DCs pulsed with 10 jlg/ml
of gp33 peptide displayed 87 and 85 % specific lysis of peptide-pulsed targets
respectively (Table 2). M~s coated with 10 jlg/ml of peptide were able to induce 48 and
60% specific lysis respectively in two animals (Table 2). In this experiment the
background level of kiling in animals primed with non-pulsed APCs was 4% in one
animal and 0. 3 % in the other animal. Taken together the intracellular IFN- y and the 
vivo cytolysis assays indicate that M~s and DCs are both able to stimulate naIve P- 14 T
cells to become fully functional effector cells.
Macrophages And Dendritic Cells Can Stimulate The Generation Of T Cell
Memory
Even though priming with M~s leads to the formation of a pool of effector cells,
it was stil a formal possibility that the stimulation of naIve T cells by M~s would not
lead to the formation of memory T cells. To evaluate this issue , we analyzed mice 40
days after they were injected with CFSE-Iabeled transgenic P-14 T cells and primed with
peptide-pulsed or unpulsed APCs.
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Table 2: P- 14 T Cells Become Cytolytic After In Vivo Priming.
14 T cells were adoptively transferred into C57BL/6 mice. One day later, the animals
were immunized with M~s or DCs pulsed with 10 r-g/ml of gp33. Four days after
immunization, spleens from congenic mice were harested and divided into 2
populations: one population was CSFE labeled and unpulsed and the other population
was labeled with one-third the amount ofCFSE and pulsed with gp33. lOx10 pulsed
and lOx10 unpulsed splenocytes were mixed together and injected IV into the primed
hosts. After 18 hours, the spleens were removed and staned for CD45. 1 and analyzed by
F ACS. Percent lysis was calculated as described in the Materials and Methods.
This experiment is representative of 3 experiments with a total n=9 mice/group.
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Table 2: Induction of Cytolytic Activity in P-14 T Cells After In Vivo Priming
Sample % Lysis
Control
DC 10 J.glml 87%
85%
Mo 10 J.glml 48%
60%
Since intravenous inoculation of APCs led to a larger pool of effectors , we chose this
route of immunization for these experiments. Memory cells were identified as
transferred T cells that had undergone a complete loss of CFSE and survived days
(Asano and Ahmed, 1996). Table 3 shows the results from two mice. In animals
injected with gp33-pulsed M~s 10.5 and 24.8 % of the P- 14 T cells in the lymph nodes
had gone on to become memory cells. The percentages of P- 14 memory cells in the
spleen were slightly lower in these same animals , 2.2 and 15. 1 % , respectively. The
percentages of memory transgenic T cells observed in the animals primed with
intravenously administered DCs were 5.9 and 8 % in the spleen. Slightly higher
frequencies of memory cells were observed in the lymph nodes of these same animals,
6 % and 13.7 % respectively. Very few CFSE negative P- 14 T cells were identified in
the mice injected with unpulsed DCs or M~s , as expected. These data demonstrate that
M~s and DCs prime similar numbers of memory cells.
To test whether M~s primed memory cells were fuctional, we stimulated these
cells ex vivo with 5!-g/ml peptide for 5 hours and performed intracellular IFN-y cytokine
staining. Results from a typical experiment are shown in Table 4. In the anals
receiving unpulsed APCs less than 1.5 % of the transgenic T cells could be stimulated to
synthesize IFN-y in ths time period in either the lymph nodes or the spleen. In contrast
animals that received gp33-pulsed M~s or DCs had a substatial population (between
18-35 %) ofIFN-y secreting transgenic P- 14 T cells. Therefore, M~s and DCs stimulate
the generation of similar levels of fuctional memory cells.
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Table 3: Priming OfP-14 T Cells By Macrophages Leads To Memory
Cell Formation.
CFSE-Iabeled P- 14 T cells congenic for CD90. 1 were adoptively transferred IV into
C57BL/6 mice. On day later, 1x10 APCs were given IV. After fort days, spleens and
inguinal lymph nodes were removed, stained and analyzed by F ACS. Memory cells were
defmed as CDS CD90. 1 + CSFE- present in the lymphoid organs afer 40 days. The data
from a representative experiment are presented as % of CDS cells that are memory cells.
This experiment was repeated 3 times with a total n=10 mice/group.
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Table 3: Priming ofP-14 T Cells With M Leads to the Formation of
Memory Cells
Immunizing APC % memory cells in % memory cells in
lymph node spleen
DC 10JJg/ml mouse 1
DC 10JJg/ml mouse 2 13.
10JJg/ml mouse 1 24. 15.
10JJg/ml mouse 2 10.
No Antigen 1.68 1.69
Table 4: Priming ofP-14 T Cells by Macrophages Leads to Functional
Memory.
CFSE labeled CD90.1 + P- 14 T cells were adoptively transferred into C57BL/6 mice.
One day later, M~s or DCs pulsed with 10 g/ml ofgp33 were given intravenously.
Fort days later, spleens and lymph nodes were removed and stained for CDS. CD90.
and intracellular IFN -y. The data are represented as % of CDS+ CD90. 1 + CFSE- cells
secreting the cytokine. This experiment was repeated 3 times with a tota n=6
mice/group.
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=r. Table 4: Priming ofP-14 T Cells by M Leads to Functional Memory
::1
APC Type % IFN+ 14 T cells in % IFN+ 14 T cells in
Lymph Node Spleen
No Antigen 1.02 1.03
DC 10 Jlglml 18. 35.
10 Jlglml 24. 32.
To determine whether or not M~s could prie endogenous polyclonal nontransgenic T
cells, C57BL/6 mice were immunized intravenously with either M~s or DCs pulsed with
10 g/ml of the gp33 peptide. Mice were rested for 40 days to allow for the formation of
memory T cells. The mice were then challenged with 5x10 plaque forming unts of
LCMV. Four days later spleens were harested and homogenized and plaque assays
were performed. The results from a typical experiment can be seen in Fig. 15.
Immunization with either M~s or DCs led to parial protection in these mice. These data
demonstrate that M~s can prime naive T cells and that these primed T cells can offer
protection to a viral challenge.
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Figure 15: Both Macrophages and Dendritic Cells Induce Protective
Immunity.
C57BL/6 mice were immunzed with either M~s or DCs pulsed with
5!-g/ml of gp33 peptide. Mice were rested for 40 days to allow for the formation of
memory T cells. The mice were than challenged with 5x10 plaque forming unts of
LCMV. F our days later spleens were harested and homogenized and plaque assays
were performed. The data are represented as Log PFU. Student T tests were performed and
the data were statistically significant p= .000004 for DCs and p= .000067 for M~s when
compared to the anals immunzed with unpulsed APCs. The difference in protection
offered between the 2 APC types was not statistically significant p=0.56. This
experiment is representative of3 experiments with a total n=13 mice/group.
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Chapter IV: Macrophages And Dendritic Cells Directly Prime
Naive CDS+ T Cells
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Results
Visualization Of A PC- T Cell Clusters
Since in wild type mice the possibilty of priming of the transgenic T cells by host
APC exists , we decided to perform a series of experiments to examine the role of cross-
presentation. The first indication we had that the transferred APCs were actually the ones
priming the transgenic T cells came from fluorescent microscopy studies. Using T cells
labeled with Cell Tracker green and APCs labeled with Cell Tracker orange, we were
able to observe the clustering of the transgenic T cells with the adoptively transferred
DCs and M~s. Figure 16 panel A shows a representative cluster of a transferred
SIINFEKL-pulsed DC with OT-I T cells and panel B shows a SIINFEKL-M~ OT-I T
cell cluster. This figure also allows for the visualization of some T cell division indicated
by the dimmer levels of green fluorescence in some T cells.
Macrophages And Dendritic Cells Directly Prime CDS+ T Cells In Fl Chimeric
Mice
Whle the studies above suggest that the transferred APCs are responsible for the
antigen presentation, it was stil possible that cross-presentation, the transferring of
peptide to the host APCs occured. To distinguish between the possibilities, we used
mice whose bone marow- derived APCs lack the appropriate MHC I molecule needed to
present the peptide potentially transferred from the injected M~s. In one set of
experiments we used radiation bone marow chimeras. H- x H- (bxs) F1 mice were
lethally irradiated and reconstituted with bone marrow from mice that were either H-2 b
or H-2 s
115
Figure 16: Visualization of Antigen Presenting Cell and T cell
Interactions.
5x 10 CFSE labeled CD90. 1 + OT - I T cells were adoptively transferred into C57BL/6
mice. One day later, the mice were immunzed SC with M~s or DCs pulsed with
OV A-p. Twenty-four hours (panel A) and fort-eight hours (panel B the draing lymph
nodes were removed and frozen in a dry ice ethanol bath. 25 11m cryosections were made
and examned by fluorescent microscopy and analyzed by Z-axis deconvolution softare.
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Figure 16 : Visualization of Antigen Presenting Cell and T Cell
Interactions
OT -1 T cell and DC cluster
=APC
OT-l T cell and M cluster
=T CELL
APCs from H-2 s mice are unable to present KA VYNFATC whereas H- APCs can
present this peptide (Fig. 17). The chimeric mice were allowed to rest for 3-4 months and
the replacement of their APCs was tested by adoptively transferring CFSE -labeled TCR
transgenic T cells and immunizing with the 13mer (the LCMV peptide
KA VYNFATCGIFA). This peptide has previously been shown to be able to prime T
cells and can be cross-presented on H- (Ciupitu et aI. , 1998). P- 14 transgenic T cells
were stimulated to proliferate in F1 mice that were reconstituted with H- bone marrow
and immunized with exogenous antigens (Fig. 18). In contrast, the transgenic T cells
failed to be stimulated by these antigens in chimeras reconstituted with H- bone marrow
(Fig. 18). These results demonstrated that the F1 host's bone marrow- derived APCs had
been completely replaced and consequently the s bxs chimeras were unable to cross-
present antigen on H- class I molecules.
We next tested whether transferred P- 14 T cells were stimulated in chimeric mice
by KA VYNFATC-pulsed M~s or DCs that were injected intravenously. Figure 19
demonstrates that M~s are able to stimulate proliferation of CFSE-Iabeled P-14 T cells in
the H- BM reconstituted chimeras. In this figure the different traces represent
individual mice. The variability between mice seen in this experiment is typical and
maybe due to the variability in injection of the bone marrow used to reconstitute these
mice. In some experiments the ability of both DCs and M~s to stimulate P- 14 T cells to
proliferate was slightly reduced in the s bxs chimeras as compared to C57BL/6 mice,
but not different from that seen in the b bxs chimeras; presumably this was attributable
to an effect of radiation and/or bone-marrow reconstitution.
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Figure 17: Generation of Fl Chimeras.
This is a schematic representation of how the F 1 chimeras were generated. B6XSJL F 
mice were lethally iradiated. Twenty-four hours later the mice were reconstituted with T
cell-depleted bone marow from either C57BL/6 or BlO. mice. The mice were
housed for 3. 0 months to allow for reconstitution of all bone marow derived APCs.
119
'?",.
Figure 17 : Construction of H2 B6SJL Fl Bone Marrow Chimeras
B6 SJL Fl
Reconstitute with bone marrow
\--
BI0. C57BL/6
12-16 Weeks
BI0. 6 SJL Fl C57BL/6 -- B6 SJL Fl
Figure 18: Test of Chimera Reconstitution.
3 .Ox 1 0 CFSE-Iabeled CD90. 1 + P- 14 T cells were transferred into bone marow chimeras.
One day later, the mice were imunized with 1.0 x10 APCs IV. Four days later
inguinal lymph nodes were removed and staned with APC conjugated anti-CD90. 1 and
PerCP conjugated anti-CDS. The above panels are gated on CDS , CD90. 1 + live cells.
The different colored lines represent different anmals in the same experiment. In every
experiment 2 anmals were immunized with the 13 mer to test for chimera reconstitution.
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Figure 19: Macrophages Prime Naive P-14 T Cells in Bone Marrow
Chimeras.
Sx10 CFSE-labeled CD90. 14 T cells were transferred into bone marow chimeras.
One day later, the mice were immunzed with 0.5x10 APCs in the footpad. Unpulsed
APCs and the LCMV 13mer were used as the negative and positive control. Four days
later, the drainng lymph nodes were removed and stained with APC conjugated anti-
CD90. 1 and PerCP conjugated anti CDS. The above panels are gated on CDS , CD90. 1 +
live cells. The different colored lines represent different anals in the same experiment.
This experiment was repeated 6 times with a total n=24 mice/group.
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Figure 19: Macrophages Prime Naive P-14 T Cells in Bone Marrow Chimeras
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Since the s bxs chieras lack bone marow-derived APCs that can present peptide on
, we conclude that the peptide-pulsed M~s are directly priming the T cells in these
bone-marow chimeras.
To establish that the P- 14 transgenic T cells directly primed in the chimeric mice
differentiated into effector T cells, we analyzed whether they were producing IFN-y by
intracellular staining. One day after P- 14 T cell transfer, chimeric mice were immunzed
intravenously with gp33 pulsed APCs. Thee days later, the mice were sacrificed and
intracellular cytokine stainng was done on the in vitro restimulated sp1enocytes. Priming
with both M~s and DCs stimulated P-14 transgenic T cells to differentiate into IFN-
secreting effector T cells in s bxs chimeras (Fig. 20). In agreement with the results seen
in wild type mice, only P-14 cells that had undergone multiple rounds of cellular division
were capable of producing significant amounts of ths cytokie in ths assay (Fig. 20). If
these primed chimeric animals were rested for 40 days, P- 14 fuctional memory cells
were also present and able to make IFN-y (Table 5).
Macrophages And Dendritic Cells Directly Prime T Cells In p2m "Knockout" Mice
To fuer examine the impact of cross-primig in these responses, we transferred
CFSE-Iabeled P- 14 T cells into f32-microglobulin deficient mice, whose bone-marow-
derived APCs and other cells lack MHC I molecules. The transgenic P- 14 T cells did not
proliferated in the f32-microglobulin knockout mice when they were immunized with the
13mer but did proliferate in C57BL/6 mice injected with this peptide (Fig. 21).
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Figure 20: Macrophages Directly Prime P-14 T Cells To Produce IFN-
CFSE-Iabeled CD90. 1 + P- 14 T cells were transferred into bone marow chimeras. One
day later, the mice were immunized with 0.5x10 APCs in the footpad. Unpulsed APCs
and the LCMV 13mer were used as the negative and positive control. Four days later, the
drainng lymph nodes were removed and stained with APC-conjugated anti-CD90. 1 and
PerCP conjugated anti CDS. The above panels are gated on CD8 , CD90. 1 + live cells.
The data are plotted as CFSE content of transgenic cells producing IFN-y. The numbers
in the left hand corner are percentage of transgenic cells producing IFN-y. This
experiment is representative of 3 experiments with a total n=5 mice/group.
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Figure 20: Macrophages and Dendritic Cells Directly Prime P-14 Effector Function
No antigen Mcp 10J.glml DC 10J.glml Bmer
36% 15. 81% 1.94%
S"'bxs
0.4% 17.5% 63%
:oxs
CFSE
Table 5: P-14 CDS+ T Cells Primed By Macrophages Differentiate Into
Functional Memory Cells In Bone Marrow Chimeras.
CD90. 1 + CSFE-Iabeled P-14 T cells were adoptively transferred into BM chimeras. One
day later, the mice were immunized IV with 1x10 M~a or DC pulsed with
g/ml of gp33 peptide or 5 g/ml of the 13mer as a positive control. Fort days later
inguinal lymph nodes and spleens were removed and stimulated in vitro 
with 5 g/ml
gp33 in the presence of Brefeldin A. The samples were then stained for CD90. , CD8
and intracellular IFN-y and analyzed by FACS. These data are shown as % P-14 T cells
containing IFN-y. This experiment is representative of 3 experiments with a total n=7
mice/group.
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Table 5: Functional Memory Cells are Present in Fl Chimeras 40 days after Priming
% IFN-y + P-14 T % IFN-y + P-14 T
cells in the Lymph cells in the Spleen
Node
B6-- bxs 13 mer 5 
p.g
59. 63.
B6-- bxs DC Nag 1.49 1.75
B6--bxs DC 10 
p.g 
Iml 13. 35.
B6-- bxs M 10 p.g Iml 22. 36.
WT DC Nag 1.02 1.13
WT DC 10 
p.g 
Iml 18. 35.
WT M 10 Jig Iml 24. 32.
S--bxs 13 mer 5 
p.g
1.12
S-.xs DC 10 p.g Iml 10. 40.
-- 
bxs M 10 p.g/ml 18. 34.
These results confirm that the f32-microglobulin deficient mice are unable to cross-
present antigen, as expected. Gp33-pulsed APCs were injected subcutaneously and three
days later the draining lymph node were removed and analyzed by FACS. In this
system , M~s were able to stimulate the P- 14 T cells at peptide concentrations of 10 and
100 pg/ml in f32m knockout mice, the same as observed in wild type mice (Fig. 21). The
DCs were also able to prime naive T cells in the f32-microglobulin deficient mice to the
same level as in the wild type mice. In addition , in the f32-microglobulin deficient
experiments DCs and M~s stimulated P- 14 T cell proliferation to the same extent.
These experiments were also done using a peptide-pulsed macrophage and dendritic cell
line. The results of this experiment can be seen in Fig. 22. As previously demonstrated
in wild type mice , both cell lines were able to stimulate T cell proliferation, further
supporting the abilty of M~s to directly prime naive T cells. To demonstrate that the P-
14 T cells directly stimulated by M~s became effectors , intracellular IFN-y staining was
performed as described above on f32m knockout mice that had been immunized with DCs
and M~s. Priming with both M~s and DCs led to the differentiation of P- 14 T cells into
IFN-y-secreting effectors (Figure 23). The percentage of terminally divided P- 14 T cells
able of making IFN-y is similar irrespective of the APC doing the stimulating. Together
with the chimera data, these results demonstrate that M~s can directly stimulate naIve T
cell responses.
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Figure 21: Macrophages Directly Prime Naive P-14 CD8+ T Cells In
2m Deficient Mice.
CD45. 1 congenic P- 14 T cells were CFSE-Iabeled and adoptively transferred into f32m
deficient hosts. One day later, mice were immunzed SC with DCs or M~o pulsed with
1 0 g/ml or 1 00 g/ml of gp3 3. The draining lymph node was removed 4 days later and
stained for CDS and CD45. 1. The data are displayed as CFSE content of the live
CD45. 1 + and CD8+ and the different colors represent the results of 2 or 3 different mice.
This experiment was repeated 4 times with a total n=12 mice/group.
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Figure 21: M s Directly Priming Naive P- 14 CD8+ T Cells in 2m Deficient Mice
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Figure 22: The M(I And DC Cell Lines Directly Prime Naive P-14 T
Cells In p2m Deficient Mice.
CD90. 1 + T cells were CFSE-Iabeled and transferred into f32m knockout mice. One day
later, C2.3 (a M~ cell line) or DC2.4 (a DC cell line) cells pulsed with gp33 were
injected SC. Four days later, popliteal lymph nodes were removed. The lymph node
cells were analyzed by FACS. The data are represented as CFSE content ofCD90.
CD8+ T cells. The different color lines represent different mice in the same experiment.
This experiment was repeated 2 times with a total n=8 mice/group.
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Figure 22: Cell Lines Directly Primes Naive P- 14 T Cells in 132m Deficient Mice
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Figure 23: Macrophages Prime Naive T Cells to Become Effector T
Cells in 2m Deficient Mice
CD45.1 congenic P- 14 T cells were CFSE-Iabeled and adoptively transferred into f32m
Deficient hosts. One day later, mice were immunized SQ with gp33-pulsed DC (10
g/ml) or M~ (1 00 g/ml). The draining lymph node was removed 4 days later and
stained for CDS and CD45. 1. The data are displayed as CFSE content of the live
CD45. 1 + and CDS+ producing IFN-y. The numbers in the left corner represents the
percentage of transgenic T cell producing IFN-y. This experiment is representative of 3
experiments with a total n=l 0 mice/group.
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Figure 23: Macrophages Prime Naive T Cells to Become Effector T Cells in 132m Mice
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Since a small amount of priming was seen when T cells pulsed with gp33 were
used as APCs in wild type mice (Fig. 13), we repeated these experiments in f32-
micro globulin knockout mice. T cells were unable to stimulate naIve P- 14 T cells in the
class I-deficient mice (Fig. 24), indicating that the limited proliferation of transgenic T
cells in wild type mice stimulated by peptide-pulsed T cells , was most likely due to cross-
presentation. Taken together these experiments clearly indicate that M~s can directly
prime naive T cells. Once primed these primed T cells go on to gain effector function as
indicated by cytolytic activity and IFN-y secretion. In addition, T cells primed by both
M~s and DCs generate a pool of memory T cells. These memory T cells are able to
secrete IFN-y in an intracellular cytokine assay.
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Figure 24: Most Of The Priming Observed When T Cell APCs Are
Given IV Is By Cross-Presentation.
CD45. 1 congenic P- 14 T cells were CFSE-Iabeled and adoptively transferred into f32m
Deficient hosts. One day later, mice were immunzed IV with OT -I/Rag 
1- T cells, DCs
or M~o pulsed with 10 !-g/ml or 100 !-g/ml of gp33. The draining lymph node was
removed 3 days later and stained for CD8 and CD45. 1. The data are gated on live
CD45.1 + and CD8 T cells and is displayed as CFSE content of transferred cells. The
different color lines represent different mice in the same experiment. This experiment
was repeated 2 times with a total n=8 mice/group.
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Figure 24: All Priming by T Cells When Injected Intravenously is Cross Presentation
Lymph Node Spleen
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Chapter V: Macrophages And Dendritic Cells Prime Naive
CD4+ T Cells In flvo
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It is known that the requirement for the priming of CD4+ and CDS T+ cells and
their dependence on costimulatory signals can be different. In light of these facts, we
decided to perform a limited set of experiments to test the hypothesis that bone marow-
derived M~s could prime naive CD4+ T cells. To test this hypothesis , we took advantage
of the D011. 10 TCR transgenic mice. These mice have CD4+ T cells specific for the
ovalbumin peptide 329-339 (ISQA VHAAHINEAGR) bound to the MHC II , IA d
molecules. An additional benefit to using this mouse is the existence of a clonotypic
antibody anti-KJl-26 allowing for easy trackig of antigen specific T cells. In these
Class II experiments we hoped to answer the same kind of questions addressed in the
Class I system. Can the M~s prime naive T cells? If so, do the T cells gai effector
function?
Results
Macrophages Prime Naive cn.r T Cells When Administered Subcutaneously
In contrast to what was seen in the class I system, M~s were only weakly able to
induce proliferation of naive T cells. For these experiments, lymph node T cells were
isolated from D011. 10 transgenic anmals and labeled with CFSE. 5x10 transgenic
T cells were transferred into BALB/c hosts and one day later the anals were
immunzed with 0.5x10 peptide-coated APCs. On day 4, the drainng lymph node was
removed. Lymph node cells were stained with the clonotypic antibody and anti-CD4 and
analyzed for proliferation by FACS. Figure 25 and 26 and shows the results of typical
experiments.
141
Figure 25: Titration of Peptide Needed for Priming ofDOll.10 T Cells
by Dendritic Cells.
5x10 CFSE labeled CD4+ T cells were transferred in BALB/c hosts. One day later, the
mice were immunzed with 0.5x10 DCs pulsed with varous concentration of OV A 323-
339 SC. On day 4 , draining lymph nodes were removed and stained with the clonotypic
antibody KJl-26 and anti-CD4 and analyzed by FACS. Data are shown as CFSE content
of the transgenic T cells. Ths experiment was repeated 6 times with a total n= 12
mice/group.
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Figure 25: Titration of Peptide Needed for Priming of DOll.10 T Cells by DCs
No Antigen
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Figure 26: Titration of Peptide Needed for Priming 
of DOl1.10 T Cells
by Macrophages.
A. 5x10 CFSE labeled CD4+ T cells were transferred into BALB/c hosts. One day
later, the mice were imunzed with 0.5x10 M~s pulsed with 10 and 100 I-g/ml
OV A 323-339 SC. On day 4, draining lymph nodes were removed and stained with
the clonotypic antibody KJ1-26 and anti-CD4 and analyzed by FACS. The
different color lines represent individual anmals in the same group. Data are
shown as CFSE content of the transgenic T cells. Ths experiment was repeated 3
times with a total n=6 mice/group.
B. 5x10 CFSE labeled CD4+ T cells were transferred into BALB/c hosts. One day
later, the mice were imunzed with 0.5x10 M~s pulsed with 10 and 100 I-g/ml
of OV A 323-339 SC. On day 4, drainng lymph nodes were removed and stained
with the clonotypic antibody KJl-26 and anti-CD4 and analyzed by F ACS. The
different color lines represent individual anmals in the same group. Data are
shown as CFSE content of the transgenic T cells. This experiment was repeated 3
times with a total n=6 mice/group.
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Figure 26A: Titration of Peptide Needed for Priming of DOll.10 T Cells by M
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Figure 26B: Titration of Peptide Needed for Priming ofDOll.10 T Cells by M~s
100 JAglml
100
qo 10 10 10 
...
DC 10 JAglml No Antigen
U ' I' 10 10 10 10 10 10 10 10 10 
CFSE
. -
Stimulation of the transgenic T cells with DCs pulsed with as little as 1 flg/ml of cognate
peptide led to significant proliferation of the DO 11. 1 0 T cells (Fig.25). In contrast, Fig
26 panel A demonstrated that M~a are much poorer stimulators of CD4+ T cells and
require up to 100 flg/ml of the same peptide. In later experiments stimulation with M~s
led to better stimulation than in earlier experiments, but never to the same level as the
DCs (panel B).
The Effect Of IFN-y Stimulation On The Ability Antigen Presenting Ability To CD
T Cells
Since DCs express higher levels of MHC class II molecules than M~s (Fig. 1),
we thought ths might account for the lesser stimulatory ability of the M~s. In order to
up-regulate the expression of class II on the surace of the APCs, we stimulated the cells
with IFN-y. Stimulation of APC with IFN-y is known to up-regulate various molecules
involved in antigen processing and presentation including MHC I and MHC II levels
(Kuby, 1997). The results of anmals immunzed with APCs stimulated with IFN -yare
shown in Fig. 27. Much to our surrise, stimulation ofDCs with IFN-y led to diminished
abilty to stimulate the CD4+ T cells in our system. This reduction in priming ability was
more strongly observed when DCs pulsed with lower peptide concentrations were used as
APCs. We did not investigate the basis for this negative effect ofIFN-y stimulation.
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Figure 27: The Effect of IFN-y on the Abilty of APCs to Stimulate
CD4+ T cells.
5x10 CFSE labeled CD4+ T cells were transferred in BALB/c hosts. Half of the M~s
and DCs were cultued for the last 48 hours in either IFN-y or media. One day after T
cell transfer, the mice were imunized with 0.5x10 OVA 323-339 pulsed APC treated and
untreated with IFN-y. On day 4, drainng lymph nodes were removed and stained with
the clonotypic antibody KJI-26 and anti-CD4 and analyzed by F ACS. The different
color lines represent individual anmals in the same group. Data are shown as CFSE
content of the transgenic T cells. This experiment was repeated 3 times with a total n=6
mice/group.
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Cytokine Production Of The DOll. lO T Cells Primed In Vivo
Next we examined the ability of the T cells primed by the two APCs to
differentiate into effectors. Several studies have previously shown that priming with
different APCs can lead to a skewing ofthe Th1 , Th2 profies of the cells (Croft et aI.
1992; Desmedt et aI. , 1998; Duncan and Swain, 1994). Another possibility was that the
T cells were stimulated to enter division, but did not differentiate into effector cells. The
results from a representative experiment can be seen in Table 6. The in vivo priming of
DO 11. 1 0 T cells with DCs led to populations of cells producing all the cytokies
examined. In contrast and surrisingly, priming by M~s led to the T cells producing
only IL-2. This experiment was repeated 4 times and the same trend was always
observed. We found these results quite intriguing because the T cells stimulated by M~s
didn t display a ThO, Th10r Th phenotype. Since anergic cells are unable to produce IL-
2 these data suggest these T cells are actully activated. We are curently repeating these
experiments in a second transgenic mouse model whose T cells see the same peptide
presented on IA , OT-II mice. These mice should allow us to evaluate the role of host
APCs in this system as well as allow us to evaluate whether or not memory cells are
generated in this system.
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Table 6: Percentage Of DOl1.10 T Cells Secreting Cytokines.
5x10 CFSE labeled CD4+ T cells were transferred in BALB/c hosts. One day later, the
mice were imunized with 0.5x10 M~s or dendritic pulsed with various concentration
of OVA 323-339 sc. On day 4, draining lymph nodes were removed incubated with 10
flg/ml ofOV A 323-339 for 5 hours in the presence of Brefeldin A The samples were then
stained with the clonotypic antibody KJI-26 and anti-CD4 and analyzed by F ACS. Data
are shown as percent of KJ 1- + cells producing the various cytokies. Background
staining with isotype control IgG was always less than 0.4%. The experiment was
repeated 4 times with a total n=6 mice/group.
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Table 6: % DOll.10 T Cells Secreting Cytokines
Cytokine
antigen 111g1ml 10 l1g1ml 10 l1g1ml 100 l1g1ml
IL- 21. 14.
GM-CSF 1.09 1.12 1.06
IFN- 1.13 1.11
IL- 1.51 0.49
TNF 1.2 15.
1.53
Chapter VI: How Do CD8+ T Cells Eliminate The Antigen Presenting
Cell?
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In addition to studying how APCs stimulated T cells , we were also interested in the
reciprocal question of how T cells influenced the APCs. At the time I initiated
experiments to explore this question, little was known about the fate of the APCs. Ingull
et at. had reported an interesting observation. Using an adoptive transfer model , these
authors imaged the interaction of peptide pulsed DCs with antigen specific T cells in the
draining lymph node by fluorescent microscopy. Using CD4+ T cells and splenic DCs
labeled with fluorescent dyes, they demonstrated that the maximum numbers of
transferred DCs were present at 24 hours. Another observation made by these authors
was that in the animals that received DCs pulsed with the transgenic T cells cognate
peptide , there were no APCs in the lymph node by the 48 hour time point, whereas
unpulsed DCs were stil present in LNs after 72- hours. The authors concluded that the
antigen presentation event must be a terminal one for the antigen-presenting cell. Since
the T cell used in this study were CD4+ T cells it was speculated that the kiling of the
APC occurred through a Fas-FasL mechanism, however no experiments were performed
to investigate this idea (Ingull et aI. , 1997). I decided to explore whether a similar
phenomenon occurred when DCs presented antigen to CD8+ T cells and to investigate
whether known cytotoxic mechanisms used by CD8+ T cells might be involved in this
process. While my experiments were in progress, a number of papers were published on
this subject (discussed below)
153
Results
Possible Role Of Fas-FasL Interactions In The Antigen Specifc Elimination Of DCs
OT - I transgenic T cells were transferred intravenously into wild type hosts. The
next day DCs from either Fas-deficient or wild type mice pulsed with various peptide
concentrations and CFSE labeled were injected into the hind footpad. The draining
lymph node was removed 48 or 72 hours later. The popliteal lymph nodes were digested
with collagenase and DNase to make single cell suspensions. The samples were then 
on a F ACS caliber counting 500 000 large forward side scatter cells as previously
described by Hermans et al. (Hermans et aI. , 2000). This F ACS method was validated
using DCs from transgenic mouse expressing GFP under the control of the class I
promoter. Figure 28 shows the liberation of the GFP+ DC as well as the disappearance of
the DCs at high antigen concentrations. This figure demonstrates that we are able to
liberate the DCs and accurately visualize them by F ACS analysis. In addition, Fig. 28
shows that the elimination of the peptide-pulsed DCs is dependant on the presence of
antigen specific T cells.
Although there are many molecules involved in inducing death in taget cells, we
chose to begin ths study looking at whether or not Fas-FasL interactions played a role in
the elimination of the APC after presenting to CD8+ T cells. Fas is a member of the TNF
superfamily and upon ligation the Fas expressing cell will undergo an apoptotic program.
Fas is expressed on a varety of cell types including T cells, B cells, M~s and DCs
however, the expression of FasL is more tightly regulated and is restricted to M~s , DCs
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Figure 28: Assay For Disappearance For Pulsed Dendritic Cells.
5x10 CFSE labeled OT-I/GFP+ transgenic T cells were adoptively transferred into
C57BL/6 mice. One day later, anmals were immunized SC with unpulsed or OV A-
pulsed (100 g/ml) DCs. Seventy-two hours later, draining lymph nodes were removed
and digested with collagenase and DNase. The samples were then analyzed by F ACS.
500 000 large forward side scatter events were collected. The data are shown as the
percentage of large cells expressing GFP.
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Figure 28: Assay For Disappearance for Pulsed Dendritic Cells
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and activated T cells. Fas plays an important role in CD4+ T cell homeostasis and a
lesser role in CDS+ T cells homeostasis. CD4+ and CDS+ T cells can also both use Fas-
FasL as a method oflysing target cells. Expression ofFas by activated T cells and has
been shown to lead to APC death of DCs, M~s and B cells in vitro (Ashany et al. , 1995;
Oddo et aI. , 1998; Sad et aI. , 1996; Stenger et aI. , 1997).
In order to examine the possible role of Fas in the observed DC disappearance
DC were grown from the BM of Fas-deficient mice (Lpr) and transferred into wild type
hosts that had received wild type OT-I transgenic T cells the previous day. Data from a
representative experiment from the original set of experiments can be seen in Figure 29.
The Y-axis indicates percentage of cells disappearg and the x -axs shows APCs inj ected
into the footpads of the mice. At the limiting antigen concentration of 100 ng/ml, SO%
of wild type DCs are eliminated by 4S-hours, whereas all of the Fas-deficient APCs stil
remain in the node. Pulsing the DCs with 1 !-g/ml of SIINFEKL led to almost total
elimination of the wild type cells and about a 50% disappearance of the Fas deficient
cells. In contrast, at the highest antigen concentration tested, 10 !-g/ml, Fas plays no role
in the antigen specific DCs disappearance observed. In later experients, even a small
role for Fas at lower antigen concentrations could not be seen. Figure 30 shows an
example from ths set of experiments. In ths set of experiments, the antigen specific T
cells were able to eliminate the Fas deficient DCs and well as the wild type DCs, even at
low peptide concentrations. From these experiments it was concluded that if Fas-FasL
interactions playa role in the disappearance of the DCs, its role is minor.
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Figure 29: Fas Deficient DCs Have Increased Longevity.
5x10 CFSE labeled OT-I transgenic T cells were adoptively transferred into C57BL/6
mice. One day later, animals were immunzed SC with CFSE labeled wild type or Fas
deficient DCs. The DCs were pulsed with varous concentrations of OV A-p or incubated
with media alone as a control. Fort-hours later, draining lymph nodes were removed
and digested with collagenase and DNase. The samples were then analyzed by F ACS.
500 000 large forward side scatter events were collected. The anmals that received DCs
from C57BL/6 mice are shown in dark blue and the anmals that received DCs from Fas
deficient mice are shown in the tuquoise. The data are shown as the percentage of large
cells expressing CFSE. Ths experiment was repeated 3 times with a total n=6
mice/group.
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Figure 29 : Fas Deficient DCs Have Increased Longevity
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Figure 30: Fas Has No Effect On DC Longevity.
5x10 CFSE labeled OT-Itransgenic T cells were adoptively transferred into C57BL/6
mice. One day later, anmals were immunized SC with CFSE labeled wild type or Fas
deficient DCs. The labeled DCs were pulsed with various concentrations of OV A-p or
incubated with media alone as a control. Fort-hours later, draining lymph nodes were
removed and digested with collagenase and DNase. The samples were then analyzed by
F ACS. 500 000 large forward side scatter events were collected. The anmals that
received DCs from C57BL/6 mice are shown in dark blue and the anals that received
DCs from Fas deficient mice are shown in the tuquoise. The data are shown as the
percentage of large cells expressing CFSE. Ths experiment was repeated 6 times with a
total n=12 mice/group.
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Figure 30: Fas Has No Effect On DC Longevity
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This conclusion is consistent with that of other labs that performed similar experiments
published after we finished these studies (Loyer et aI. , 1999; Ludewig et aI., 2001).
Possible Role Peiforin In The Antigen Specifc Elimination Of DCs
Although CD4+ T cells are restricted to killng by Fas, CD8+ T cells can also use
perf orin to kill target cells. Once CD8+ T cells become activated they produce perf orin
and granmes and store them in granules. The granmes are serpins and are actually
the death-inducing molecules. Once a CTL binds to its taget, perf orin forms pores
through which the granmes are exocytosed in to the taget cell. The target cell wil
then undergo apoptosis. Perf orin has been shown to be necessar for clearance of LCMV
and Listeria as well as elimination of tuor cells. On the other hand, perf orin is
dispensable for protection to vesticular stomatitis virus and vaccinia virus (Kagi et aI.
1996).
Since activated CD8+ T cells become CTL effectors, it is possible that the OT-I T
cells eliminate the peptide-pulsed DC through expression of the effector molecule
perforin. To test this hypothesis, we bred the OT-I mice to perf orin knockout mice and
used these as effector T cells in our adoptive transfer model. Figure 31 shows the results
of a typical experiment. The use of T cells deficient in perf orin had no effect on the
magnitude of DC disappearance when assayed on day 2 at any of the peptide
concentration examined. One of the benefits of this adoptive transfer system is that T
cells and APCs with different deficiencies could be used in the same experiments. 
took advantage of this fact and used perf orin deficient OT-I T cells and Fas deficient DCs
in the same mice.
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In this case, we consistently saw a change in the percentage of DCs disappearng.
At high peptide concentrations, the absence of both Fas and perf orin led to a 50%
decrease in the ability of the T cells to eliminate the peptide-pulsed DCs. It is important
to note that half of the DCs stil did disappear, suggesting that multiply pathways regulate
this importt fuction (Fig. 31). These results seen using perf orin deficient T cells, were
confirmed in a study by Ludewig et al. These authors showed that although perf orin
played a role in the killng of peptide pulsed DCs in vitro it did not playa major role 
vivo. (Ludewig et aI. , 2001).
In conclusion, it appears multiple death pathways are involved in the elimination
of antigen presenting cells by primed CD8+ T cells. In light of our early data showing
that Fas possibly played a role at lower peptide concentrations as well as the results of
combining Fas deficient DC with perfori deficient T cells, it is stil possible Fas-FasL
interactions playa small role in this phenomenon. These studies also suggest that
perf orin can also playa parial, but redundant role. What has become clear is the
existence of other unown players in ths pathway.
Possible Role Of Fas-FasL Interactions In The Expansion of Antigen Specifc CD8+ T
cells
One possible trvial explanation for why we not seeing disappearance may be
because the T cells were not adequately stimulated and therefore did not acquire effector
fuctions. In order to rule out ths possibility, these experiments were repeated using
congenic T cells. The use of the congenic marker, in ths case CD90. , allowed us to
quatify T cell expansion in the same experiments. These experiment were performed
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Figure 31: The Combined Effect of DC Fas Deficiency and T Cell
Perforin Deficiency.
5x10 CFSE labeled OT -I or OT -I/Perforin -/- transgenic T cells were adoptively
transferred into C57BL/6 mice. One day later, animals were immunzed SC with CFSE
labeled wild type or Fas deficient DCs. The labeled DCs were pulsed with various
concentrations ofOV A-p or incubated with media alone as a control. Fort-hours later
draining lymph nodes were removed and digested with collagenase and DNAse. The
samples were then analyzed by F ACS. 500 000 large forward side scatter events were
collected. The data are shown as the percentage of large cells expressing CFSE. Ths
experiment was repeated 3 times with a tota n=6 mice/group and the same trend was
always observed.
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Figure 31: : The Combined Effect of DC Fas Deficiency and T Cell Perforin Deficiency
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exactly as the other disappearance experiments; except some anmals were harested at
later time points and the lymph node cells were stained with APC-conjugated antibody
against CD90. 1 to quantify the expansion of antigen specific T cells. The results of this
experiment were intriguing. We had hypothesized that if we could extend the life of the
presenting APC , it would lead to a greater degree ofT cell expansion. Figure 32 a shows
the results of these experiments. We sacrificed mice at day 4 7 and 10 days afer DC
transfer. This figure shows days post DC transfer on the X-axis and % CD8+ T cell
expressing the transgenic marker on the Y-axis. Figure 32 demonstrates that when DCs
are pulsed with equal amounts of pep tides, Fas-deficient T cells leads to a lesser
expansion of the antigen specific T cells. It was possible that the T cells stimulated by
the Fas-deficient DCs proliferated earlier than those stimulated with wild type DCs. 
rule out ths possibilty, we harested lymph nodes from mice 2 , 3 and 4 days after DC
transfer. Once again, we observed lesser expansion of the OT-I transgenic T cells when
Fas-deficient DCs were used as stimulators as compared to wild type DCs pulsed with the
same amount of peptide (Fig 32b). This inability of Fas-deficient DCs to stimulate.
transgenic T cells to the same extent as wild type DC supports a role for FasL as a
co stimulatory molecule. In fact after we finished this study, two studies were published
demonstrating a role for Fas-FasL interaction as a co stimulatory signal for CD8+ T cells
but not CD4+ T cells (Suzuk and Fink, 2000; Suz et aI. , 2000). Using T cells from
FasL-deficient mice, these authors demonstrated the abilty ofFasL engagement to
166
Figure 32: Accumulation Of OV A-P Specific T Cells By Fas Deficient
Dendritic Cells.
A. 2.5x10 CD90. + OT-Itransgenic T cells were adoptively transferred into
C57BL/6 mice. One day later, anmals were immunzed SC with peptide-pulsed
wild type or Fas deficient DCs. The DCs were pulsed with varous concentrations
of OV A-p or incubated with media alone as a control. Draining lymph nodes
were removed 4 7 and 10 days later and digested with collagenase and DNase.
The samples were then analyzed by F ACS. 500 000 large forward side scatter
events were collected. The anals that received DCs from C57BL/6 mice pulsed
with 100 ng/ml are shown in dark blue and the mice pulsed with 10 ng/ml are
shown in tuquoise. DCs isolated from Fas deficient mice pulsed with 100 ng/ml
are shown in red and the DCs isolated from Fas deficient mice pulsed with 10
ng/ml are shown in fuchsia. Ths experiment was repeated 3 times with a total
n=3 mice/group.
B. The experient was performed exactly as above except lymph nodes were
removed after 2 , and 4 days. Wild type DCs pulsed with varous concentrations
ofOV A-p: no peptide (black), 10 pg/ml (orange), 100 ng/ml (blue) and 1 !-g/ml
(yellow). DCs from Fas deficient mice pulsed with various concentrations of
OV A-p: no peptide (grey), 10 pg/ml (tuquoise) and 100 ng/ml (liac). This
experiment was repeated 3 times with a total n=3 mice/group.
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Figure 32A: Accumulation of OV A-p Specifc T Cells by Fas Deficient Dendritic Cells
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Figure 32B: Overall T Cell Accumulation With Fas Deficient DC Stimulation
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increase maximal CD8 T cells proliferation when the T cells were stimulated though
their TCR. It role for FasL in increasing CD4 T cell proliferation was also shown, but
only when the abilty of the CD4 T to undergo Fas mediated death was blocked.
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Chapter VII: Discussion
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Priming Of Naive CDS+ TCells
Naive CD8+ T lymphocytes have more stringent requirements for activation than
effector T cells and hybridomas. The issue of what APC intially stimulates these T cells
in the initiation of immune responses is an important one. It is well established that DCs
can stimulate primar immune responses and our data confIrm ths point. In vitro there
is abundant evidence that M~s acquire antigen and stimulate CD8+ T cells
(Apostolopoulos et aI. , 2000; Hosono and Katsura, 1982; Torpey et aI. , 1989; Wijburg et
aI. , 1998). Our data show that M~s can also stimulate CD8+ T cells in vivo to proliferate
express effector fuctions and matue into memory cells. We have also shown that this
stimulation is due to direct stimulation of T cells by M~s and not cross-presentation by
or containation with small numbers of DCs. Based on these fmdings we conclude that
M~s can also directly prie naive T cell responses.
Our conclusion is surrising, because it has previously been argued that DCs are
the only APC that initiate priar immune responses (Banchereau and Steinman, 1998;
Jung et aI. , 2002; Norbur et al. , 2002; Steinman et aI. , 1983) and that M~s play no role
in this process. However, the published evidence supporting ths view is relatively
limited. Much of the evidence comes from in vitro experiments. Steinman and
coworkers tested varous purfied APCs in a mixed lymphocyte reaction and found that
DCs were strong activators ofT cells, whereas M~s were poor stimulators of such
responses (Steinman et aI. , 1983; Steinman and Witmer, 1978). Depleting DCs from
splenocytes with an antibody virtally eliminated their abilty to stimulate MLRs
(Steinman et aI. , 1983; Steinman and Witmer, 1978). DCs were also able to stimulate
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primar T cell responses to foreign antigen in vitro (Inaba et aI. , 1990; Inaba and
Steinman, 1986). However, it is unclear whether the in vitro experiments accurately
model the in vivo situation. Moreover, in other in vitro studies there is opposite data
indicating that other APCs can stimulate primary CD8+ T cell responses (Butz and
Bevan, 1998).
Another approach to identify the type of APCs needed to initiate CD8+ T cell
responses has been to deplete different subsets of APCs in vivo. Agents such as silica or
chlodronate-liposomes eliminate phagocytic cells in vivo and inbit the generation ofT
cell responses (Ciavara et aI. , 1997; Debrick et aI. , 1991; Nair et aI. , 1995; Wu et aI.
1994). Such experiments were originally interpreted to demonstrate a role for M~s in 
cell priing. However, it was later appreciated that imatue DCs are also phagocytic
and likely to be eliminated by these treatments (Banchereau and Steinman, 1998).
Although, one group tested their liposomes made from dichloromethylene diphosphonate
and found no DC toxicity fuher supporting a role for M~s in priming naive T cells in
their vesticular stomatitis system (Ciavara et al. , 1997).
A more selective approach for depleting DCs used transgenic mice that express
the receptor for Diphtheria toxin under the control of the CD 11 c promoter (a DC specific
promoter). Administration of diphtheria toxin selectively eliminated CD11c-positive
DCs in these transgenic mice. Using this approach, Jung et al. demonstrated that
elimination of DCs by diphtheria toxin blocked the generation of CTLs to some antigens
g. 
Listeria moncytogenes and Plasmodium yoeli (Jung et aI. , 2002). Ths data are
among the strongest to shown that DCs can play an essential role in stimulating T cell
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responses at least for certin antigens. However, whether ths is true for other antigens is
unown; in vivo some antigens may be preferentially presented on DCs while others are
also presented on M~s (see above). Also, a caveat in the diphtheria-toxin studies was the
possibility that the ability ofM~s to stimulate T cells was impaired by the toxin, e.
when M~s ingested the toxin durng phagocytosis of dying DCs.
In a set of experiments designed to visualize the APCs that interacted with naive
CD8+ T cells in situ Norbur et al. infected mice with a vaccina virs expressing EOFP
and could detect infected (EGFP-expressing) DCs and M~s in situ. When they
transferred CFSE-dye-Iabeled virus-specific T cells into these same anals, they
observed clusterig of these CD8+ T cells around EGFP-positive (infected) APC.
Although M~s made up :; 60% of inected cells, clusters were observed only around the
infected DCs. Although ths was interpreted to show that only DCs were stimulating the
T cells, T cell stimulation was actually being inerred. What was actully measured, T
cell-APC clustering, is infuenced by strength of adhesion, chemokines and potentially
other factors. In fact, DCs can cause T cells to cluster under some circumstaces, even in
the absence of specific antigen (Inaba and Steinman, 1986). Ths analysis would also fail
to detect single T cells that were stimulated and/or ones that had detached from an APC.
Moreover, a substatial component of the T cell response to vaccinia occurs though
cross-priming (Norbur et aI. , 2001; Rairez and Sigal, 2002; Sigal et aI. , 1999) and the
APCs involved in this process would not express EGFP from the vaccina recombinants.
Consistent with a cross-priming mechansm, T cells were observed to cluster with EGFP-
negative cells and many of these latter cells lacked DC markers. These finding are also
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limited to vaccinia virus. Finally, these experiments did not rule out the possibilty of
priming by the infected M~s, nor did it show a correlation between the observed T cell
clustering and the acquisition ofT cell effector fuction (Norbur et aI. , 2002).
In summar, DCs can stimulate primar T cell responses and may be paricularly
potent in doing so. However, the evidence that they are the only cells that can prime
responses and that M~s lack this capabilty is relatively scarce. It is possible that DCs
are the principal APCs for presenting some antigens (e.g. Listeria and Malara). On the
other hand, our data unambiguously demonstrate that M~s can also stimulate naIve CD8+
T cells in vivo. Our data additionally demonstrate that this observed presentation is
direct presentation and not cross-presentation, since it occurs in two model systems
where cross-presentation is not possible.
How do M~s compare to DCs in stimulating T cell responses? In vitro DCs are
reported to be 100- 1000 times more potent APCs than M~s. Interestingly, however
these two APCs can cross-present exogenous antigen with simlar effciency (Shen et aL
1997). Therefore, the difference in stimulating T cells in vitro may be due to lower levels
of co stimulatory molecules and/or MHC class II molecules on M~s. However, the
expression of both MHC and costimulatory molecules on M~s can be increased upon
activation of these cells thereby increasing their potency in vivo. In vivo we also find
differences in the potency of M~s compared to DCs, although ths appears to be most
related to the ability of these cells to migrate to lymphoid tissue. When the M~s are
injected subcutaeously, it takes 10-fold more antigen to prie naive T cells compared to
DCs; in contrast, when the APCs are injected via an intravenous route, they are of equal
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potency at the same antigen concentration. Moreover, we have shown that quadrupling
the number of M~s injected subcutaeously results in the priming of equivalent
responses. In fact, when we quantified the number of M~s and DCs that migrated and
compared the magnitude ofT cell responses they stimulated, M~s in the lymphoid
tissues were actully more potent than DCs. However, such a comparson makes the
assumption that the recovery ofM~s and DCs from lymphoid organs is similar when we
dissociate the tissue to quantify APC migration; we don t know if ths assumption is
valid. In any case , we conclude that M~s are bone fide stimulators ofT cells.
An importt implication of these findings is that the number ofM~s versus DCs
present at a site of antigen deposition may influence which of these cells wil contribute
more to priming of CD8 T cells. Durng infamation, there is a large increase in the
number ofM~s from recruitment and proliferation. Under these conditions, M~s are
much more numerous than DCs (Bryant and Ploegh, 2004; Croft et aI. , 1992; Meier et aI.
2003). Therefore, M~s could be the dominant APC in many situations, paricularly
infection. Since all of the experiments in this thesis used peptide pulsed cells, it is
possible that different forms of antigen may be presented better by one cell type. 
addition, it also possible that tissue or peritoneal M~s could have different propensities
for presenting different forms of antigen as well as varing abilities to present antigen.
Another interesting observation that might affect the potency of APCs, was the
shorter half-life of SIINFEKL-MHC class I complexes on M~s compared to DC. The
peptide-complexes on immature DCs have a half life of about 3 days and those on matue
DCs (CDSO/CD86, class II high cells) are remarkably stable with a half life of;:96 hours.
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This observation suggests that once a DC matues, its peptide-MHC class I molecules are
some how stabilized and/or their rate of tuover is decreased (Guermonprez et aI. , 2002;
Rescigno et aI. , 1998; Zehn et aI. , 2004). Whether this difference in the half-life of
MHC complexes on M~s and DCs makes a difference in their ability to stimulate
immunity in vivo is not yet clear. The long half-life of complexes on DCs may not lead
to longer stimulation of T cells because the DCs are rapidly eliminated after presenting
antigen to T cells (Hermans et al. , 2000; Ingulli et aI. , 1997) (see also ths thesis). On the
other hand, it is possible that the shorter half-life of the MHC class I complex on M~s
may be offset by the continuous production of new peptides (in situtions involving the
processing from whole antigens).
Priming Of Naive Cells
In vitro there is abundant evidence that M~s acquire antigen and stimulate CD4
T cells (Askonas et aI. , 1968; Hsieh et aI. , 1993a; Hsieh et al. , 1993b; Kahert et al. , 2000;
Nair et al. , 1995; Unanue and Askonas, 1968; von Delwig et aI. , 2002). Moreover, it is
also well established that in vitro M~s can tae up and present pariculate and cell-
associated antigens on MHC class I and class II molecules (Brut et aI. , 1990;
Kovacsovics-Banowski et aI. , 1993; Kovacsovics-Banowski and Rock, 1994; Rock et
aI. , 1993). Similarly, M~s have been isolated from anmals injected with viruses
(Hamilton-Easton and Eichelberger, 1995; Usherwood et aI. , 1999) or soluble antigen
(Grant and Rock, 1992) and shown to present antigen to CD4 T cells ex vivo.
Interestingly, in some studies DCs are the only antigen-bearng APCs isolated from
antigen-injected animals (den Haa et aI. , 2000). In vivo the presentation of antigen by
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M~s to T cells is clearly important for type IV hypersensitivity responses and clearance
of intracellular pathogens. In all of these situations M~s are stimulating previously
activated (effector) T cells or hybridomas.
The identity ofthe APC responsible for CD4+ T cell priming in vivo is stil an
open question. Some studies have shown that the APC responsible depends on the form
of antigen. Using I-E transgenic mice, Constant et al. demonstrated that although
presentation of peptide antigen required DCs, presentation of whole protein antigen
required the presence ofB cells (Constat et aI. , 1995a). Many other studies have
demonstrated a role for DCs in the priing of naive CD4+ T cells (Erb et aI. , 1996; Flohe
et aI. , 1998; Inaba et aI. , 1993; Ingull et aI., 1997; Ingull et aI. , 2002; Steinman et aI.
1983; Steinan and Witmer, 1978). It is also possible that the route of immunization as
well as the form of antigen playa role in which APC can prime CD4+ T cells populations.
Inguili et al. demonstrated that although B cells, M~s, CD11b+ and CD8 DCs all take
up soluble OVA delivered subcutaeously, only the CD11b DC population was able to
prime naive CD4+ T cells (Ingull et aI. , 2002). Others studies have shown that M~s
pulsed with peptide ex vivo can stimulate CD4+ T cells (Croft et aI. , 1992; Duncan and
Swain, 1994).
Since we were using CD4+ T cell proliferation as a marker of T cell activation
and since proliferation has been shown not to always lead to effector fuction, we wanted
to determne whether the M~ primed CD4+ T cells developed into effector T cells (Adler
et aI. , 2000). Adler et al. demonstrated, using mice that express high and low levels of
hemagglutinin (HA) on their peripheral cells, that antigen dose is not all that determines
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tolerance versus activation of T cells. They went on to demonstrate that even though the
level of HA expression vared 1000 fold in these 2 types of mice , the T cells became
tolerant to the self-antigen in both systems. In addition, the transgenic T cells from both
the high and low expressers proliferated for the same number of divisions and at the same
rate when they encountered viral expressed HA. It can be concluded from this study that
insuffcient stimulation ofT cells because of low peptide-MHC complexes is not what
leads to tolerance induction in this system (Adler et al. , 2000).
A role for the type of APC in the skewing of CD4+ helper cell development has
also been demonstrated (Constat et aI. , 2002; Desmedt et aI. , 1998; Duncan and Swain
1994; Glimcher and Murhy, 2000; Rissoan et al. , 1999). Desmedt et af. have shown that
M~s pulsed with peptide ex vivo can infuence whether or not the CD4+ T cells
differentiate into ThO, Th1 or Th cells. These authors went on to show that stimulation
of CD4+ T cells with M~s strongly favored Th1 cell development. In addition, it was
also shown that stimulation of CD4+ T cells with M~s could also suppress already
developing Th2 cell responses (Desmedt et aI., 1998). Studies by Maldonado-Lopez
demonstrated the ability of different DC populations to inuence the ability of CD4+ T
cells to develop into Th1 or Th cells in vivo. Where as immunzation of mice with
antigen-pulsed CD8+ DC led to the T cells differentiating into Th1 type cells,
immunization of mice with antigen-pulsed CD8- DC led to the development ofT cells
with a Th2 phenotype (Maldonado-Lopez et aI. , 1999). This group fuher demonstrated
that the abilty of the DCs to skew T cells development depended upon the abilty to
secrete certin cytokines. In addition, the ability of CD8a + DCs produce IL- 12 and
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preferentially stimulate CD4+ T cells to become Th1 cells was also demonstrated
(Maldonado-Lopez et aI. , 2001). It has also been demonstrated that myeloid DCs lead to
the development ofTh2 cells possibly by the secretion ofIL-6 (Diehl and Ricon, 2002).
There has also been data suggesting a role for antigen dose and structue. Experiments
involving the use of altered peptide ligands have demonstrated a role for strengt of TCR
signal in determning lineage commitment (Glimcher and Murhy, 2000).
In light of the above-mentioned studies, we wanted to investigate whether the
priming of the naive D011. 10 T cells by the M~s allowed the CD4+ T cells to express
effector fuction. In addition, we wanted to evaluate the ability of DCs and M~s to
induce the secretion of various effector cytokies. We chose to use intracellular cytokie
staining as the method of detection for the cytokines. The cytokines used to identify Th
profie were: IL-2 and GM-CSF for ThO cells, IFN-y and TNF-a for Th1 , and IL-4 for
Th2. Using this model, we analyzed whether or not the stimulated T cells underwent
multiple rounds of cell division and gained effector fuction. We found that M~s could
indeed stimulate naive CD4+ T cells to proliferate and secrete IL-2. In addition it was
demonstrated that DCs also primed naive T cells to undergo multiple rounds of cell
division. In contrast to M~s stimulated T cells, the DC primed T cells were able to
secrete IFN-y, TNF-a, IL- , IL-4 and GM-CSF. These data suggest that DCs stimulate
CD4+ T cells to gain a greater range of effector fuctions than M~s.
The mechansms that underlie these differences wil be of interest to investigate in
future studies. In addition, although, the finding that M~s can initiate CD4+ T cell
responses is an important one there are still many unanswered questions in the CD4+ T
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cell system. Do the stimulated T cells become memory cells? Is the adoptively
transferred cell the APC responsible for the priming or is the peptide being transferred to
host APCs? If the T cells become memory cells, are these cells stil fuctional? And
finally, would the macrophage primed CD4 T cells be able to offer protection form an
antigenic challenge?
Issues Related To Priming Of Both CD And CDS+ T Cells
Monocytes can differentiate into both M~s and DCs. It has been reported that
monocytes can captue antigen in peripheral tissue and subsequently convert into DCs
once they migrate into the lymph node (Randolph et aI. , 1999). It has also been reported
that the fate of differentiating monocytes can be determined by migration pattern. Using
a transendothelial trafficking model, Radolph et al. showed that monocytes cultued
with endothelium, especially after phagocytosing paricles, became DCs and then
migrated ablumenal-to-Iuminally. In ths same model , it was shown that monocytes that
stayed in the sub endothelial network differentiated into M~s (Randolph et al., 1998). 
addition, in vitro experiments performed by Palucka et al. demonstrated that M~s and
DCs are capable of interconverting until very late in the differentiation pathway. The
authors suggest that the cytokine environment may provide the signal that designates the
cells fmal fate (Palucka et aI. , 1998).
Is it possible that such a conversion into DCs underlies the abilty ofM~s to
stimulate immune responses in our experiments? First, it should be noted that even if this
were to occur, our data would stil indicate that in tissues, M~s (i.e. before converting to
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DCs) are another APC that fuction in tissues as sentinel cells for immune surveilance.
Moreover, we find that stable M~ clones are also able to directly prime naive T cells.
Our studies have used peptide-pulsed M~s to demonstrate the potential of these
APCs to initiate immune responses. Is it likely that M~s can stimulate primar T cell
responses to other kinds of antigen? Several lines of evidence argue that the answer to
this question is yes. It is well established that M~s acquire antigens from pathogens 
vivo and present them to T cells. This is basis for host defense against many intracellular
pathogens and type IV hypersensitivity responses. Moreover, M~s isolated from anmals
injected with proteins can be shown to have processed and presented antigen on both
MHC class I and II molecules (Grant and Rock, 1992). Therefore, M~s clearly acquire
antigens in vivo and generate peptide MHC complexes. In addition, M~s in peripheral
tissues that have acquired foreign material migrate to regional lymph nodes (Kota et aI.
1979; Shi and Rock, 2002) and we confIrm ths ability of antigen-bearing M~s to
migrate into secondar lymphoid organs. M~s that reside in the lymph nodes and spleen
also perform a fitering fuction and captue antigen present in blood or lymph (Maino
and Joris, 2004). Such M~s are present in the T cell zones of the secondar lymphoid
organs (Maino and Joris, 2004). Therefore, M~s do acquire antigens from peripheral
tissues, process and present them as peptide-MHC complexes in T cell regions of
secondar lymphoid organs. Our data demonstrate that presentation of such peptide-
MHC complexes by M~s wil prime T cell responses.
Are M~s and DCs the only cells that can initiate T cell responses? Kundig et at.
have shown that fibroblasts transfected with viral proteins directly induced the generation
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of viral specific CTL when injected directly into the spleen (Kundig et aI. , 1995). This
observation suggests that a key factor makig an APC a "professional" APC is its ability
to home to the secondar lymphoid organ allowing it to encounter many T cells in the
perfect environment. In addition, a new cell type termed fibrocyte, a blood-borne
fibroblast like cell , has recently been demonstrated to be able to prime naive T cells.
These cells were found to express collagen receptors as well as express many of the same
markers as professional APCs such as MHC II and costimulatory molecules. It has also
been shown that fibrocytes can migrate to the lymph node and present antigen with an
effciency approaching that ofDCs (Chesney et aI. , 1997). These experiments suggest
that any antigen-bearng cell that migrates to lymph nodes can initiate T cell responses.
However, since many experiments have demonstrated that bone marow-derived APCs
are necessar for the initiation of immune responses (Huang et aI. , 1994a; Huag et aI.
1994b; Iwasaki et aI. , 1997; Sigal et al. , 1999; Sigal and Rock, 2000), fibroblasts are
unlikely to playa role in the priming of T cell responses in physiological situations. In
addition, our experiments using T cells as APCs demonstrate that the abilty of an
antigen-bearing cell to migrate into the lymph nodes is not sufficient to initiate responses.
These T cell APCs, when pulsed with peptide , present as many peptide-MHC complexes
as M~s and upon injection in vivo migrate to paracortical (T cell) region of the lymph
node; however, they fail to directly prime imune responses. It is possible that B cells
can prime naive T cell responses in vivo although this has been controversial. The
abilty ofB cells to prime naive T cells has not been tested in our system. However, it is
known that B cells are poorly phagocytic and usually don t cross-present antigens (Rock
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et aI. , 1993); therefore they are unlikely to be importnt for initiating response to many
microbial pathogens and cell-associated antigens.
Summary for T Cell Priming Studies
Because bone marow APCs play an essential role in detecting infection and
initiation of responses, these observations raise many important questions. In what
setting do M~s initiate immune responses? Do T cells stimulated by M~s exhbit
different specificities than those primed by DCs? Since these two APCs may make
different mediators and thereby infuence responses in different ways, the intiating APC
may playa role in determinig whether protective immunty is generated. Are the T
cells primed by M~s fuctionally different from the T cells primed by DCs? It is
possible that different APC will process antigen differently and prime different
repertoires of T cells. These differences could affect the affinities and avidities of the
TCR of T cells primed by the different APC subsets. Ths would be an importt
distinction since, e. , there is evidence that higher affnity T cells are more likely to
clonally exhaust. These lower affinity/avidity T cells would play an important role in
disease states were there is a high load of antigen like hepatitis or HIV. It will also be of
interest to examine the interactions and synergies between different APCs.
The Role Of Fas And Perforin In APC Disappearance
When we began these experiments very little was known about the fate of the
antigen-presenting cell after presentation. A couple of studies had observed the
disappearance of the APC in animals that had received transgenic T cells specific for the
peptide used to pulse the transferred APC. As discussed above , Inguili et al. had
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demonstrated the absence of peptide-pulsed DCs in the draining lymph nodes of animals
that had received CD4+ transgenic T cells specific for that peptide, suggesting that
antigen presentation is a terminal event for DCs (Ingull et aI. , 1997). Another study,
designed to examine why DC immunization could not cause tuor rejection suggested
that ths phenomenon also applied to CD8+ T cells. Using a FACS method to quantitate
CFSE labeled adoptively transferred SIINFEKL pulsed DCs in the lymph nodes ofOT-
mice, Hermans et aZ. also discovered that the T cells eliminate the epitope specific
antigen presenting cells, therefore limiting the stimulatory abilty of the peptide-pulsed
DCs (Hermans et aI. , 2000). The mechanism of disappearance was not elucidated, but
since these were CDS+ T cells the role for both Fas-FasL and perf orin was possible.
Another bias in ths study was the use of the OT-I transgenic anial as a host. In these
animals -:90 % of the T cells are specific for the antigen in question, so elimination of the
DC may not be a physiologically relevant event. Both of these studies speculated on the
possible mechanisms involved, but this question was not investigated (Hermans et aI.
2000; Ingull et aI. , 1997).
A study done by Loyer et aZ. investigated the mechansm of DC disappearance by
looking at the role ofFas and Perf orin. In their study they used wild type mice as hosts
in order to have a normal T cell repertoire. They transferred transgenic T cells specific
for the male HY antigen and peritoneal M~s as APCs into the host animals. Using this
protein, they were able to examine the fate of the APC caring a dominant epitope
versus a nondominant epitope. In this system, the authors found that APCs presenting
immunodominant epitopes did indeed disappear, very shortly after entering the lymph
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node, but only when presenting to MHC I restricted T cells. In contrast, APCs
presenting non-dominant epitopes were not eliminated. These authors went on to show
that although Fas-FasL interactions played no role in the observed APC elimination
perf orin played a parial role. These results suggest that the epitope presented may
dictate the fate of the presenting cell and that when immunodominant epitopes are used it
may not be possible to extrapolate the results to other epitopes (Loyer et aI. , 1999). In
contrast to these findings, Kawamura et aZ. showed that Langerhan cells were eliminated
within 48 hours from the lymph node when they were used as APCs and that this
elimination was delayed, but not absent in Fas or FasL deficient mice. These studies
additionally demonstrated that the Langerhan express Fas in the draining lymph node and
that activation of the cells with IFN led to the fuher upregulation ofFas expression
(Kawamura et aI. , 1999; Kawamura et aI. , 2000).
In 2001 , a study performed by Ludewig et aZ. the role ofFas and perf orin in the
observed APC disappearance was investigated in a LCMV model. This group took
advantage of the H8 mouse, which expresses the immunodominant epitope from
LCMV' s gp33 constitutively. By adoptively transferrng these cells into DC primed
primed animals they showed they were unable to boost the gp33 specific responses. Ths
group went on to show that this inability to boost the immune responses by repeated
immunzation with peptide-pulsed DCs was because the APC were eliminated.
Additional experiments demonstrated that although DC kiling in vitro was clearly
dependent on perf orin, neither perf orin nor fas played a role in vivo (Ludewig et aI.
2001).
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Several conclusions can be made from the data in the literatue and our data. Our
study demonstrates that if Fas-FasL interactions playa role, it is a small one and is only
evident at lower antigen concentrations. In addition, our experiments as well as the
observations made by Ludewig et a/. argue against a major role for perforin in ths
observed APC elimination (Ludewig et aI. , 2001). Our data also demonstrates that when
both Fas and Perforin are not available there is a reduction in the CD8+ T cells ' ability to
eliminate the APCs at lower antigen concentrations. It is interesting to note that 50% of
the pulsed APCs are stil eliminated in the absence of both effector molecules.
Therefore, it is clear that multiple redundant mechansms are involved in the antigen
specific elimination of DCs.
These disagreements about the contributions ofFas and perf orin to the observed
DC disappearance between the varous studies may be due to multiple factors. First and
foremost, maybe CD4+ T cells and CD8+ T cells utilize different mechansms to eliminate
the peptide pulsed APCs. Another possibility is that the natue of the antigen and or
whether or not it is a dominant epitope dictates the fate of the presenting APC as
suggested by Loyer et a/. (Loyer et aI. , 1999). It is possible that in these different
studies, different APC subsets are presenting and that these subsets differ in how they are
eliminated. And finally, it is stil formally possible that the elimination of the presenting
APC is not mediated by the activated antigen specific T cells, but is an intrnsic activity
of the APC when it is signaled that its job is done.
The issue of how the longevity of DCs affects immune responses is an interesting
one for many reasons. The half-life of DCs may determine how long T cells are
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stimulated and thereby infuence responses. It is possible that by extending the life of the
APC , the number of T cells stimulated could be greatly increased. This increase in
stimulated T cells could result in an increase in the number of effector T cells and
therefore memory cells. On the other hand, it is also possible that the potential increase
in activated T cells may result in an increase in T cells undergoing activation induced cell
death or in clonal exhaustion. These questions stil need to be investigated and the
adoptive transfer model could prove useful in these experiments. The abilty to increase
the number of activated T cells while decreasing the magnitude of the contraction stage
would allow for the formation of a larger memory pool. The ability to manpulate APCs
would give immunologists another possible place to make vaccines more effective. How
to increase effector cell numbers and increase effecter memory has become the "holy
grail" of vaccine development.
Other interesting questions stil remain. If the DC is indeed killed by the
activated antigen specific T cells, what molecules playa role? Are the molecular
players" different for CD4+ verses CD8+ T cells? Other TNF receptor famly members
such as TRAIL are potential candidates that have yet to be tested. If death is intrnsic to
the DCs, a role for molecules involved in the regulation of the apoptosis such as Bcl-
family members will need to be investigated. Another importt question is are all APCs
eliminated after they present antigen? It is possible that M~s and B cells mayor may not
be subject to the same fate as DCs. It wil also be interesting to investigate whether T
cells use different effector molecules to eliminate different APCs.
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